US20100249273A1 - Polymeric articles comprising oxygen permeability enhancing particles - Google Patents
Polymeric articles comprising oxygen permeability enhancing particles Download PDFInfo
- Publication number
- US20100249273A1 US20100249273A1 US12/721,081 US72108110A US2010249273A1 US 20100249273 A1 US20100249273 A1 US 20100249273A1 US 72108110 A US72108110 A US 72108110A US 2010249273 A1 US2010249273 A1 US 2010249273A1
- Authority
- US
- United States
- Prior art keywords
- composition
- oxygen permeable
- oxygen
- particles
- barrer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002245 particle Substances 0.000 title claims abstract description 147
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 146
- 239000001301 oxygen Substances 0.000 title claims abstract description 146
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 146
- 230000035699 permeability Effects 0.000 title claims abstract description 48
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 126
- 229920000642 polymer Polymers 0.000 claims abstract description 91
- 239000000017 hydrogel Substances 0.000 claims abstract description 41
- 239000000463 material Substances 0.000 claims description 60
- -1 polydimethylsiloxane Polymers 0.000 claims description 59
- 239000002086 nanomaterial Substances 0.000 claims description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- 229910001868 water Inorganic materials 0.000 claims description 36
- 229920001577 copolymer Polymers 0.000 claims description 23
- 239000000178 monomer Substances 0.000 claims description 23
- 239000007789 gas Substances 0.000 claims description 19
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 19
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 16
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 16
- 229920001223 polyethylene glycol Polymers 0.000 claims description 15
- 125000002091 cationic group Chemical group 0.000 claims description 13
- 239000000693 micelle Substances 0.000 claims description 13
- 125000000129 anionic group Chemical group 0.000 claims description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims description 11
- 238000000576 coating method Methods 0.000 claims description 10
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 9
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 9
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 8
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 7
- 239000008199 coating composition Substances 0.000 claims description 7
- 229920001519 homopolymer Polymers 0.000 claims description 7
- 239000002502 liposome Substances 0.000 claims description 7
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 6
- 239000011737 fluorine Substances 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 229910044991 metal oxide Inorganic materials 0.000 claims description 6
- 150000004706 metal oxides Chemical class 0.000 claims description 6
- 229920006294 polydialkylsiloxane Polymers 0.000 claims description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 5
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 claims description 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- 229910052582 BN Inorganic materials 0.000 claims description 4
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 4
- 238000007720 emulsion polymerization reaction Methods 0.000 claims description 4
- 108010047185 gas vesicle protein Proteins 0.000 claims description 4
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 claims description 3
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 3
- NUXLDNTZFXDNBA-UHFFFAOYSA-N 6-bromo-2-methyl-4h-1,4-benzoxazin-3-one Chemical compound C1=C(Br)C=C2NC(=O)C(C)OC2=C1 NUXLDNTZFXDNBA-UHFFFAOYSA-N 0.000 claims description 3
- OXJGJKIURHREKH-UHFFFAOYSA-O CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C Chemical compound CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C OXJGJKIURHREKH-UHFFFAOYSA-O 0.000 claims description 3
- 150000002739 metals Chemical class 0.000 claims description 3
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 claims description 3
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 claims description 3
- OMNKZBIFPJNNIO-UHFFFAOYSA-N n-(2-methyl-4-oxopentan-2-yl)prop-2-enamide Chemical compound CC(=O)CC(C)(C)NC(=O)C=C OMNKZBIFPJNNIO-UHFFFAOYSA-N 0.000 claims description 3
- PNLUGRYDUHRLOF-UHFFFAOYSA-N n-ethenyl-n-methylacetamide Chemical compound C=CN(C)C(C)=O PNLUGRYDUHRLOF-UHFFFAOYSA-N 0.000 claims description 3
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052723 transition metal Inorganic materials 0.000 claims description 3
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 230000001788 irregular Effects 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims 1
- 229920002994 synthetic fiber Polymers 0.000 claims 1
- 239000011257 shell material Substances 0.000 description 32
- 229920001296 polysiloxane Polymers 0.000 description 27
- 239000004094 surface-active agent Substances 0.000 description 25
- 238000000034 method Methods 0.000 description 24
- 239000011541 reaction mixture Substances 0.000 description 21
- 239000004530 micro-emulsion Substances 0.000 description 19
- 239000003999 initiator Substances 0.000 description 18
- 239000000523 sample Substances 0.000 description 14
- 239000000839 emulsion Substances 0.000 description 13
- 239000003085 diluting agent Substances 0.000 description 12
- 230000002209 hydrophobic effect Effects 0.000 description 11
- 239000003431 cross linking reagent Substances 0.000 description 10
- 239000006185 dispersion Substances 0.000 description 10
- 238000006116 polymerization reaction Methods 0.000 description 10
- 229910052710 silicon Inorganic materials 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- 238000009826 distribution Methods 0.000 description 9
- 239000011859 microparticle Substances 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000002270 dispersing agent Substances 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 239000010703 silicon Substances 0.000 description 6
- 229920002554 vinyl polymer Polymers 0.000 description 6
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 5
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000002296 dynamic light scattering Methods 0.000 description 5
- 238000005538 encapsulation Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 4
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102100035526 B melanoma antigen 1 Human genes 0.000 description 4
- 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229920006037 cross link polymer Polymers 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229910010272 inorganic material Inorganic materials 0.000 description 4
- 239000011147 inorganic material Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000012703 microemulsion polymerization Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000003505 polymerization initiator Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 230000000087 stabilizing effect Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000002834 transmittance Methods 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 3
- WOGIJMKNTVKVHV-UHFFFAOYSA-N [1-hydroxy-2-methyl-3-(2-methylprop-2-enoyloxy)-3-silyl-1,1-bis(trimethylsilyloxy)hexan-2-yl] 2-methylprop-2-enoate Chemical compound C(C(=C)C)(=O)OC(C(OC(C(=C)C)=O)(C(O)(O[Si](C)(C)C)O[Si](C)(C)C)C)(CCC)[SiH3] WOGIJMKNTVKVHV-UHFFFAOYSA-N 0.000 description 3
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 3
- GUCYFKSBFREPBC-UHFFFAOYSA-N [phenyl-(2,4,6-trimethylbenzoyl)phosphoryl]-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)P(=O)(C=1C=CC=CC=1)C(=O)C1=C(C)C=C(C)C=C1C GUCYFKSBFREPBC-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- LWMFAFLIWMPZSX-UHFFFAOYSA-N bis[2-(4,5-dihydro-1h-imidazol-2-yl)propan-2-yl]diazene Chemical compound N=1CCNC=1C(C)(C)N=NC(C)(C)C1=NCCN1 LWMFAFLIWMPZSX-UHFFFAOYSA-N 0.000 description 3
- 229920001400 block copolymer Polymers 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910021389 graphene Inorganic materials 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229910052752 metalloid Inorganic materials 0.000 description 3
- 150000002738 metalloids Chemical class 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 229920001521 polyalkylene glycol ether Polymers 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000009736 wetting Methods 0.000 description 3
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
- NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 description 2
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- NMZSJIQGMAGSSO-UHFFFAOYSA-N 3-[[1-amino-2-[[1-amino-1-(2-carboxyethylimino)-2-methylpropan-2-yl]diazenyl]-2-methylpropylidene]amino]propanoic acid Chemical compound OC(=O)CCNC(=N)C(C)(C)N=NC(C)(C)C(=N)NCCC(O)=O NMZSJIQGMAGSSO-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- LFOXEOLGJPJZAA-UHFFFAOYSA-N [(2,6-dimethoxybenzoyl)-(2,4,4-trimethylpentyl)phosphoryl]-(2,6-dimethoxyphenyl)methanone Chemical compound COC1=CC=CC(OC)=C1C(=O)P(=O)(CC(C)CC(C)(C)C)C(=O)C1=C(OC)C=CC=C1OC LFOXEOLGJPJZAA-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 229920006318 anionic polymer Polymers 0.000 description 2
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 2
- 239000003618 borate buffered saline Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 239000004811 fluoropolymer Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000005251 gamma ray Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 239000010954 inorganic particle Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- REOJLIXKJWXUGB-UHFFFAOYSA-N mofebutazone Chemical group O=C1C(CCCC)C(=O)NN1C1=CC=CC=C1 REOJLIXKJWXUGB-UHFFFAOYSA-N 0.000 description 2
- WVFLGSMUPMVNTQ-UHFFFAOYSA-N n-(2-hydroxyethyl)-2-[[1-(2-hydroxyethylamino)-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCO WVFLGSMUPMVNTQ-UHFFFAOYSA-N 0.000 description 2
- QYZFTMMPKCOTAN-UHFFFAOYSA-N n-[2-(2-hydroxyethylamino)ethyl]-2-[[1-[2-(2-hydroxyethylamino)ethylamino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCNCCO QYZFTMMPKCOTAN-UHFFFAOYSA-N 0.000 description 2
- RQAKESSLMFZVMC-UHFFFAOYSA-N n-ethenylacetamide Chemical compound CC(=O)NC=C RQAKESSLMFZVMC-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 2
- 229920000636 poly(norbornene) polymer Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000000935 solvent evaporation Methods 0.000 description 2
- 239000004071 soot Substances 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000003746 surface roughness Effects 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000007669 thermal treatment Methods 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- CPUDPFPXCZDNGI-UHFFFAOYSA-N triethoxy(methyl)silane Chemical compound CCO[Si](C)(OCC)OCC CPUDPFPXCZDNGI-UHFFFAOYSA-N 0.000 description 2
- ZNOCGWVLWPVKAO-UHFFFAOYSA-N trimethoxy(phenyl)silane Chemical compound CO[Si](OC)(OC)C1=CC=CC=C1 ZNOCGWVLWPVKAO-UHFFFAOYSA-N 0.000 description 2
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 2
- 150000004072 triols Chemical class 0.000 description 2
- UKRDPEFKFJNXQM-UHFFFAOYSA-N vinylsilane Chemical class [SiH3]C=C UKRDPEFKFJNXQM-UHFFFAOYSA-N 0.000 description 2
- 229910001928 zirconium oxide Inorganic materials 0.000 description 2
- YXMISKNUHHOXFT-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) prop-2-enoate Chemical group C=CC(=O)ON1C(=O)CCC1=O YXMISKNUHHOXFT-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- VNQXSTWCDUXYEZ-UHFFFAOYSA-N 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione Chemical compound C1CC2(C)C(=O)C(=O)C1C2(C)C VNQXSTWCDUXYEZ-UHFFFAOYSA-N 0.000 description 1
- LGJCFVYMIJLQJO-UHFFFAOYSA-N 1-dodecylperoxydodecane Chemical compound CCCCCCCCCCCCOOCCCCCCCCCCCC LGJCFVYMIJLQJO-UHFFFAOYSA-N 0.000 description 1
- VSIKJPJINIDELZ-UHFFFAOYSA-N 2,2,4,4,6,6,8,8-octakis-phenyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane Chemical compound O1[Si](C=2C=CC=CC=2)(C=2C=CC=CC=2)O[Si](C=2C=CC=CC=2)(C=2C=CC=CC=2)O[Si](C=2C=CC=CC=2)(C=2C=CC=CC=2)O[Si]1(C=1C=CC=CC=1)C1=CC=CC=C1 VSIKJPJINIDELZ-UHFFFAOYSA-N 0.000 description 1
- NEBBLNDVSSWJLL-UHFFFAOYSA-N 2,3-bis(2-methylprop-2-enoyloxy)propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(OC(=O)C(C)=C)COC(=O)C(C)=C NEBBLNDVSSWJLL-UHFFFAOYSA-N 0.000 description 1
- LESMLVDJJCWZAJ-UHFFFAOYSA-N 2-(diphenylphosphorylmethyl)-1,3,5-trimethylbenzene Chemical compound CC1=CC(C)=CC(C)=C1CP(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 LESMLVDJJCWZAJ-UHFFFAOYSA-N 0.000 description 1
- GJKGAPPUXSSCFI-UHFFFAOYSA-N 2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone Chemical compound CC(C)(O)C(=O)C1=CC=C(OCCO)C=C1 GJKGAPPUXSSCFI-UHFFFAOYSA-N 0.000 description 1
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
- BQZJOQXSCSZQPS-UHFFFAOYSA-N 2-methoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OC)C(=O)C1=CC=CC=C1 BQZJOQXSCSZQPS-UHFFFAOYSA-N 0.000 description 1
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 1
- DVFNBWLOQWGDSH-UHFFFAOYSA-N 2-methyl-1-pyrrolidin-1-ylbutan-1-imine Chemical compound CCC(C)C(=N)N1CCCC1 DVFNBWLOQWGDSH-UHFFFAOYSA-N 0.000 description 1
- LNUDZOHDUVPVPO-UHFFFAOYSA-N 3,3-difluoro-2-(trifluoromethyl)prop-2-enoic acid Chemical group OC(=O)C(=C(F)F)C(F)(F)F LNUDZOHDUVPVPO-UHFFFAOYSA-N 0.000 description 1
- UURVHRGPGCBHIC-UHFFFAOYSA-N 3-(ethenoxycarbonylamino)propanoic acid 4-[[[[[[[[[[[[[[[[[[[[[[[[[[[4-ethenoxycarbonyloxybutyl(dimethyl)silyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]butyl ethenyl carbonate 1-ethenylpyrrolidin-2-one ethenyl N-[3-tris(trimethylsilyloxy)silylpropyl]carbamate Chemical compound C=CN1CCCC1=O.OC(=O)CCNC(=O)OC=C.C[Si](C)(C)O[Si](CCCNC(=O)OC=C)(O[Si](C)(C)C)O[Si](C)(C)C.C[Si](C)(CCCCOC(=O)OC=C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)CCCCOC(=O)OC=C UURVHRGPGCBHIC-UHFFFAOYSA-N 0.000 description 1
- YKTDNRZNBVULRO-UHFFFAOYSA-N 3-[(4-ethenylphenyl)-dimethylazaniumyl]propane-1-sulfonate Chemical compound C[N+](C)(CCCS([O-])(=O)=O)c1ccc(C=C)cc1 YKTDNRZNBVULRO-UHFFFAOYSA-N 0.000 description 1
- ZQQVWOGKEFXNNS-UHFFFAOYSA-N 3-[(4-ethenylphenyl)-dimethylazaniumyl]propanoate Chemical compound [O-]C(=O)CC[N+](C)(C)C1=CC=C(C=C)C=C1 ZQQVWOGKEFXNNS-UHFFFAOYSA-N 0.000 description 1
- BCAIDFOKQCVACE-UHFFFAOYSA-N 3-[dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azaniumyl]propane-1-sulfonate Chemical compound CC(=C)C(=O)OCC[N+](C)(C)CCCS([O-])(=O)=O BCAIDFOKQCVACE-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 241000192542 Anabaena Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 241000192685 Calothrix Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010011033 Corneal oedema Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 241001464430 Cyanobacterium Species 0.000 description 1
- 241000192534 Dolichospermum flos-aquae Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000192701 Microcystis Species 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 229920001616 Polymacon Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000008062 acetophenones Chemical class 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000010945 base-catalyzed hydrolysis reactiony Methods 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- LPTWEDZIPSKWDG-UHFFFAOYSA-N benzenesulfonic acid;dodecane Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCCCCCCCCCCC LPTWEDZIPSKWDG-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical class C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229930006711 bornane-2,3-dione Natural products 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 201000004778 corneal edema Diseases 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 238000007435 diagnostic evaluation Methods 0.000 description 1
- 238000013154 diagnostic monitoring Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- PODOEQVNFJSWIK-UHFFFAOYSA-N diphenylphosphoryl-(2,4,6-trimethoxyphenyl)methanone Chemical compound COC1=CC(OC)=CC(OC)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 PODOEQVNFJSWIK-UHFFFAOYSA-N 0.000 description 1
- VFHVQBAGLAREND-UHFFFAOYSA-N diphenylphosphoryl-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 VFHVQBAGLAREND-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 125000003010 ionic group Chemical group 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002535 lyotropic effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- 229940044591 methyl glucose dioleate Drugs 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- QRWZCJXEAOZAAW-UHFFFAOYSA-N n,n,2-trimethylprop-2-enamide Chemical compound CN(C)C(=O)C(C)=C QRWZCJXEAOZAAW-UHFFFAOYSA-N 0.000 description 1
- BUGISVZCMXHOHO-UHFFFAOYSA-N n-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]-2-[[1-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCC(CO)(CO)NC(=O)C(C)(C)N=NC(C)(C)C(=O)NC(CO)(CO)CO BUGISVZCMXHOHO-UHFFFAOYSA-N 0.000 description 1
- 239000002088 nanocapsule Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 1
- 229920002946 poly[2-(methacryloxy)ethyl phosphorylcholine] polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Chemical class 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000767 polyaniline Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000193 polymethacrylate Chemical class 0.000 description 1
- 229920000128 polypyrrole Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BWJUFXUULUEGMA-UHFFFAOYSA-N propan-2-yl propan-2-yloxycarbonyloxy carbonate Chemical compound CC(C)OC(=O)OOC(=O)OC(C)C BWJUFXUULUEGMA-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000012763 reinforcing filler Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K9/00—Use of pretreated ingredients
- C08K9/10—Encapsulated ingredients
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- C08L33/04—Homopolymers or copolymers of esters
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L43/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing boron, silicon, phosphorus, selenium, tellurium or a metal; Compositions of derivatives of such polymers
- C08L43/04—Homopolymers or copolymers of monomers containing silicon
Definitions
- the invention relates to polymeric articles comprising oxygen permeability enhancing particles and processes for forming such articles.
- Polymeric materials displaying oxygen permeability are desirable for a number of applications, including medical devices.
- One such application is contact lenses.
- GPSCL Gas permeable soft contact lenses
- Conventional hydrogels have been prepared from monomeric mixtures predominantly containing hydrophilic monomers, such as 2-hydroxyethyl methacrylate (“HEMA”), N-vinyl pyrrolidone (“NVP”) and vinyl alcohol.
- HEMA 2-hydroxyethyl methacrylate
- NDP N-vinyl pyrrolidone
- the oxygen permeability of these conventional hydrogel materials relates to the water content of the materials, and is typically below about 20-30 barrers.
- that level of oxygen permeability is suitable for short-term wear of the contact lenses; however, that level of oxygen permeability may be insufficient to maintain a healthy cornea during long-term wear of contact lenses (e.g., 30 days without removal).
- Silicone hydrogels are also currently used as materials in GPSCLs. Silicone hydrogels have typically been prepared by polymerizing mixtures containing at least one silicone-containing monomer or reactive macromer and at least one hydrophilic monomer. While this class of lens material reduces the corneal edema and hyper-vasculature associated with conventional hydrogel lenses, they can be difficult to produce because the silicone components and the hydrophilic components are incompatible. Additional material improvements to protein uptake profiles, wettability and general comfort on the eye over extended periods of time are also desirable.
- Silicone elastomer contact lenses have also been made. These lenses displayed good oxygen permeability, but had poor wettability and mechanical properties. Reinforced silica filler has been disclosed as improving the physical properties of the silicone elastomers.
- the present invention relates to a composition
- a composition comprising a polymer having distributed therein an oxygen enhancing effective amount of oxygen permeable particles having an oxygen permeability of at least about 100 barrer and an average particle size less than about 5000 nm.
- FIG. 1 is a graph of Dk vs. concentration of silicon microparticles in the polymer.
- FIG. 2 is a graph of Dk vs. silicon content.
- FIG. 3 is an SEM micrograph of an etafilcon-based lens containing 800 nm Shin Etsu POSS/PDMS micro-particles
- FIG. 4 is the Volume Distribution Histogram of Particle Sizes for SiME-OHmPDMS 20
- FIG. 5 is the Volume Distribution Histogram of Particle Sizes for SiME-OHmPDMS 40
- FIG. 6 is the Volume Distribution Histogram of Particle Sizes for SiME-OHmPDMS 60
- FIG. 7 is the Volume Distribution Histogram of Particle Sizes for SiME-OHmPDMS 80
- a “medical device” is any article that is designed to be used while either in or on mammalian tissues or fluid. Examples of these devices include but are not limited to catheters, implants, stents, and ophthalmic devices such as intraocular lenses and contact lenses.
- the preferred biomedical devices are ophthalmic devices, particularly contact lenses, most particularly contact lenses made from hydrogels.
- lens refers to ophthalmic devices that reside in or on the eye. These devices can provide optical correction, cosmetic enhancement, radiation reduction, including UV blocking and visible light or glare reduction, therapeutic effect, including wound healing, delivery of drugs or nutraceuticals, diagnostic evaluation or monitoring, or any combination thereof.
- lens includes, but is not limited to, soft contact lenses, hard contact lenses, intraocular lenses, overlay lenses, ocular inserts, and optical inserts.
- reaction mixture is the mixture of components, including, reactive components, diluent (if used), initiators, crosslinkers and additives, which when subjected to polymer forming conditions form a polymer.
- Reactive components are the components in the reaction mixture, which upon polymerization, become a permanent part of the polymer, either via chemical bonding, entrapment or entanglement within the polymer matrix.
- reactive monomers become part of the polymer via polymerization
- non-reactive polymeric internal wetting agents such as PVP
- oxygen permeable particles of the present invention became part of the polymer via physical entrapment.
- the diluent (if used) and any additional processing aids, such as deblocking agents do not become part of the structure of the polymer and are not part of the reactive components.
- the reaction mixtures of the present invention can be formed by any of the methods known by those skilled in the art to be useful to form polymeric articles or devices, and include stirring, rolling, kneading and shaking.
- biocompatibility and “biocompatible” means that the material in question does not cause any substantial negative response when in contact with the desired biological system.
- the undesirable negative responses include stinging, inflammation, undesirable levels of protein and lipid uptake, ocular cell damage and other immunological responses.
- a “hydrogel” polymer is a polymer capable of absorbing or imbibing at least about 20 weight % water, in some embodiments at least about 30 weight % water and in other embodiments at least about 40 weight % water.
- Oxygen permeable particles have an oxygen permeability of at least about 100 barrer, in some embodiments between about 100 and about 1000 barrer, and in other embodiments between about 300 and about 1000 barrers.
- the oxygen permeable particles may also have oxygen permeabilities of at least about 300, 400 or 500 barrers.
- the oxygen permeable particles of the present invention may be solid, or “filled” or may be hollow. Solid oxygen permeable particles may be formed from crosslinked polymers, for example, fluorine containing polymers, polydialkylsiloxane polymers, self-assembled siloxanes and rigid materials such as polytrimethylsilylpropyne and combinations thereof.
- the oxygen permeable particles are non-reactive means that under the conditions of formation and use of the compositions of the present invention, the oxygen permeable particles do not covalently bond to the polymer but may associate with the polymer via dipole-dipole forces such as hydrogen bond or van der Waals forces. If the oxygen permeable particles are encapsulated, either the oxygen permeable particles do not covalently bond to the encapsulating material, the encapsulating material does not bond to the polymer or both. In one embodiment the oxygen permeable particles are surface reactive to assist in dispersing and/or stabilizing the oxygen permeable particles in the selected reaction mixtures.
- Potentially anionic or cationic means that the molecule has latent ionicity.
- An example of a potentially anionic group is a carboxylate, and an example of a potentially cationic group is an amine, and particularly a tertiary amine
- the oxygen permeable particles are selected so that they do not substantially degrade the optical properties of the polymer, including color and clarity. This may be accomplished by controlling the particle size, refractive index, chemical properties of the oxygen permeable particles or any combination of the foregoing.
- the oxygen permeable particles have a refractive index of within about 20% hydrated polymer matrix and in some embodiments within about 10% of the refractive index of the hydrated polymer matrix. Other embodiments may employ oxygen permeable particles with a refractive index within about 1% of the hydrated polymer matrix and in other embodiments still, less than 0.5%.
- the oxygen permeable particles have an average particle size between about 200 and about 1000 nm and a refractive index within about 10% of the refractive index of the hydrated polymer matrix.
- Oxygen permeable particles with a particle size of less than 200 nm may have refractive indices which are within about 20% of the refractive index of said hydrated polymer matrix.
- the refractive index of the oxygen permeable particle is between about 1.37 and about 1.45.
- the refractive index of the hydrogel polymer is between about 1.39 and about 1.43 and the encapsulated oxygen permeable particles have a refractive index within the ranges specified above.
- the oxygen permeable particles are incorporated into the ophthalmic devices, and in one embodiment contact lenses in at least one region outside the optic zone.
- the opic zone is the region through which light is focused.
- larger particle sizes can be tolerated without refractive index matching.
- contact lenses made according to this embodiment may have average particle sizes of between about 200 nm and 100 microns.
- Solid oxygen permeable particles may be formed from materials including cross-linked polymers containing silicones, fluorine, and combinations thereof, oxygen permeable perovskite oxides, combinations thereof and the like.
- silicone containing polymers include polydimethylsiloxane (PDMS), cross-linked poly(dimethylsiloxane), poly((trimethyl silyl)propyne) and cross-linked poly(dimethylsiloxane) core and a polydimethylsiloxane/and a poly(silsesquioxane) (PDMS/POSS) core/shell shell available from Shin Etsu, Inc.
- fluorine containing polymers include amorphous fluoropolymers such as 2,2-bis(trifluoromethyl)-4,5-difluoro-1,3-dioxole copolymers with tetrafluoroethylene (sold under the tradename TEFLON AF), fluorinated PDMS, and fluorinated polynorbornene. Copolymers and mixtures containing the foregoing may also be used, so long as the oxygen permeable particles have oxygen permeabilities in the ranges disclosed herein.
- the solid oxygen permeable particle comprises at least one inorganic material, such as metalloids such as boron nitrides, metal oxides, including iron oxide, aluminum oxide, titanium dioxide, zirconium oxide, metals, such as gold, transition metal sulfides, such as ZnS and CdS, graphene, inorganic/organic hybrids such as whole shell metal oxides coated with cellulose, Copolymers containing the foregoing and mixtures of any of the foregoing with any of the inorganic materials may also be used.
- metalloids such as boron nitrides, metal oxides, including iron oxide, aluminum oxide, titanium dioxide, zirconium oxide, metals, such as gold, transition metal sulfides, such as ZnS and CdS, graphene, inorganic/organic hybrids such as whole shell metal oxides coated with cellulose, Copolymers containing the foregoing and mixtures of any of the foregoing with any of the inorganic materials may also be used.
- Suitable solid oxygen permeable particles have an average particle size less than 5000 nm, in some embodiments less than about 1000 nm, in some embodiments less than about 800 nm, in other embodiments less than about 600 nm and in other embodiments still, less than about 200 nm.
- the oxygen permeable particles may be hollow.
- Suitable hollow nanostructures have a rigid shell which is impermeable to water and which encapsulates or encloses a gas-filled space.
- Hollow nanostructures are permeable to gases such as oxygen and air, and have an oxygen permeability of at least about 200 barrer, in some embodiments at least about 300 barrer, in some embodiments at least about 500 barrer, and in other embodiments greater than about 1000 barrers.
- the hollow nanostructures of the present invention are known by different names including nanostructures, nanoballoons, microcapsules, gas vesicles and microspheres. Any of these known nanostructures may be used, so long as they possess the characteristics described herein.
- Suitable nanostructures include synthetic hollow nanostructures and gas vesicles.
- Gas vesicles or gas vesicle proteins
- Synthetic nanostructures comprise shells formed from polymers, metal oxides, metalloids, carbon and combinations thereof.
- the hollow nanostructures When the oxygen permeable particle is a hollow nanostructure, the hollow nanostructures have a particle size, in the longest dimension, of less than 500, in some embodiments less than about 400 nm and in other embodiments still, between about 10 and about 100 nm. In one embodiment the hollow nanostructure have an average diameter of about 20 to about 100 nm and a length of about 100 to about 500 nm.
- the nanostructures may have any closed, hollow structure, including cylindrical with closed ends, spherical, ovoid, regular and irregular polyhedra, ellipsoids, cones, spheroids (which can be described by the lengths of their 3 principal axes), and combinations thereof or irregularly shaped.
- Naturally occurring nanostructures, such as gas vesicles are frequently cylindrical with conical ends.
- Synthetic nanostructures may have any shape, and in one embodiment are selected from cylindrical and spherical structures.
- the shell of the hollow nanostructures is permeable to gases, and particularly to oxygen, and to mixtures comprising oxygen, such as air. Gases such as oxygen and air freely move through the hollow nanostructures of the present invention.
- the nanostructure shells of the present invention have oxygen permeabilities of at least about 5 barrer, in some embodiments of at least about 20 barrer. In one embodiment, the oxygen permeability of the shell is equal to or greater than the oxygen permeability of the substrate polymer. However, because the shell thickness is relatively thin (less than about 10 nm, and in some embodiments between about 1 and about 5 nm) compared to the size of the nanostructure, relatively low oxygen permeabilities of the shell materials are still useful.
- the shell materials have a modulus of at least about 1 GPa, in some embodiments at least about 2 GPa, and in some embodiments between about 2.5 GPa and about 3.5 GPa.
- Shapes which are known to be stable under pressure include spheres and cylinders, cones and spheroids (which can be described by the lengths of their 3 principal axes), and combinations thereof.
- hollow nanostructure is a sphere, and in another spheres having an average diameter of about 200 nm.
- the structures may also include reinforcing structures such as ribs, reinforcing fillers, nanofibers, structural proteins, crosslinks (ionic or covalent) combinations thereof and the like.
- the hollow nanostructures of the present invention retain their hollow structure and do not collapse during the production, sterilization and use of the articles in which they are incorporated.
- the maintenance or retention of the hollow nanostructure is characterized by a critical pressure of a least about 0.05 MPa and in some embodiments between about 0.1 MPa and about 0.3 MPa. and still other embodiments greater than 0.2 MPa.
- the outer portion of the nanostructure is hydrophilic and the inner structure is water impermeable. This allows the nanostructure to be readily dispersed in hydrophilic substrate polymers such as hydrogels, but prevents water from seeping into the gas filled cavity.
- the inner and outer structures of the nanostructure shell can be formed from separate layers, such as separate layers of polymers, proteins or other shell materials, or from a single amphiphilic material having its hydrophilic portion oriented outward, and the hydrophobic portion oriented toward the interior of the hollow nanostructure or towards an inner hydrophobic layer of the shell.
- the hydrophilicity and water permeability of materials useful for forming the nanostructure may be characterized by the water permeability coefficient at 25° C. and the surface tension.
- Hydrophilic materials suitable for the outer structure of the shell have water permeability coefficients greater than about 100 and surface tensions greater than about 40 dyne/cm at 20° C.
- Water impermeable materials for the inner structure of the shell have water permeability coefficients at 25° C. of less than about 10, and surface tensions of less than about 35 dyne/cm at 20° C.
- the hydrophilic materials display contact angles of less than about 80°
- the water impermeable materials display contact angles of greater than about 100° when measured using the Wilhelmy plate method and distilled, deionized water at room temperature.
- Water permeability coefficients for a number of polymers are reported in Polymer Handbook, 4th Edition by J. Brandrup, Immergut, E. H., Grulke, E. A., Bloch, D.
- the hollow nanostructures are formed synthetically.
- suitable synthetic methods include physicochemical processes where the shell material is precipitated during solvent evaporation or adsorption with controlled electrostatic or chemical interactions to form the shell. On example of this method is disclosed in Nature Vol 367 Jan. 20, 1994.
- the hollow nanostructures may be formed by the phase separation via solvent evaporation of a polymer mixture of two or more polymers. The interfacial tensions and evaporation rates are selected such that a spherical droplet of one polymer becomes coated with a uniform layer of the other as a result of the spreading equilibria between two fluids suspended as emulsified droplets in a solvent.
- the material from which the outer hydrophilic layer is formed may be a polymer which can be crosslinked or polymerized with itself.
- examples of such materials include homo and copolymers of 2-hydroethyl methacrylate (HEMA), polyvinyl acetate, methacrylic acid, N-vinylpyrrolidone, N-vinyl acetamide, N-vinyl methyl acetamide, N,N dimethyl acrylamide, acrylic acid, glycerol monomethacrylate, MPC (2-Methacryloyloxyethyl phosphorylcholine), methyl methacrylate, hydroxyethyl acrylate, N-(1,1-dimethyl-3-oxybutyl)acrylamide, polyethylene glycol monomethacrylate, polyethylene glycol dimethacrylate, 2-ethoxyethyl methacrylate, 2-methacryloxyethyl phosphorylcholine, combinations thereof and the like.
- HEMA 2-hydroethyl methacryl
- polymers having the water permeation coefficients and surface tensions described above may also be used. Examples include polysaccharides, hydrophilic polypeptides, polyesters, polyamides including nylons having repeating carbon sections of less than 4 carbon atoms, polyurethanes, proteoglycans, cellulose and hydrophobic backbone polymers which have hydrophilic side chains sufficient to provide the water permeation coefficients and surface tensions described above, and combinations thereof.
- Specific examples of polymers which may be used to form the outer shell include poly(acrylamide co-acrylic acid), poly(N-isopropylacrylamide), 2-hydroxymethacrylic ester containing polymers and copolymers, polyvinyl alcohol polymers and copolymers and the like.
- the polymers may have any structure, including linear, branched and brush structures.
- the outer shell is formed from a crosslinked polymer comprising at least one monomer used to form the substrate.
- materials from which an inner layer may be formed include homopolymers and copolymers comprising polyorganosiloxanes (including silicone methacrylates), fluorine containing polymers, liposomes, hydrophobic polypeptides, polyesters, polyamides, polyurethanes, polystyrenes, polyanilines, polypyrroles, combinations thereof and the like.
- suitable inorganic materials include oxygen permeable perovskite oxides, metalloids such as boron nitrides, metal oxides, including iron oxide, aluminum oxide, titanium dioxide, zirconium oxide, metals, such as gold, transition metal sulfides, such as ZnS and CdS, graphene, inorganic/organic hybrids such as whole shell metal oxides coated with cellulose, polytetrafluoroethane, combinations thereof and the like.
- Specific examples of silicone containing polymers include polydimethylsiloxane (PDMS), cross-linked poly(dimethylsiloxane), poly(silsesquioxane), poly((trimethyl silyl)propyne).
- fluorine containing polymers examples include amorphous fluoropolymers such as 2,2-bis(trifluoromethyl)-4,5-difluoro-1,3-dioxole copolymers with tetrafluoroethylene (sold under the tradename TEFLON AF), fluorinated PDMS, and fluorinated polynorbornene. Copolymers containing the foregoing and mixtures of any of the foregoing with any of the inorganic materials may also be used.
- the inner layer material may include latent reactive groups such as pentafluoromethacrylate and N-acryloxysuccinimide. Suitable latent reactive groups are disclosed in US2004/0120982 and may be added to the inner layer of the shell to allow reaction between the inner and outer layer materials.
- the inner and outer shell materials have alternating charges, allowing the materials to associate via charge interaction. Examples of such materials include carboxylic acid metal salts, carboxylic acid/quaternary ammonium salts, sulfonic acid metal salts, sulfonic acids/quaternary ammonium salts.
- the shell can be formed from one or more zwitterionic material, amphiphilic material, or combination thereof. Suitable zwitterionic and micellar materials are disclosed below.
- the amphiphilic materials are assembled such that the hydrophobic portion is oriented in toward the cavity of the nanostructure and the hydrophilic portion is oriented out toward the substrate.
- the amphiphilic material is then crosslinked to provide a nanostructure having the desired size, shape and modulus.
- the hollow nanostructures may be formed around a seed or template particle which is removed after at least part of the nanostructure is formed.
- polymerization reactions such as emulsion polymerization, microemulsion polymerization, suspension polymerization or liposome or micelle formation followed by crosslinking may be used to form the shell layer(s).
- Suitable template materials include polymeric microspheres, water-in-oil emulsion droplets, lyotropic phases exhibiting a multilamellar vesicular structure.
- the seed or template may be removed by calcination or solvent etching after the shell or at last one layer of the shell is formed.
- carbon hollow nanostructures may be formed via the thermal treatment of arc soot at more than 2400° C.
- Macromol. Mat. Eng. 2007 292, 1158-1163 “Encapsulation of Inorganic Particles with Nanostructured Cellulose”.
- the nanostructures may be naturally occurring gas vesicles isolated from bacteria, such as from cyanobacteria (such as Anabaena and Microcystis, Ocillatoria and Calothrix), methogens and halophiles.
- Naturally occurring gas vesicles may be isolated by known methods such as those disclosed in WO 98/21311, which is incorporated in its entirety by reference. Isolated naturally occurring nanostructures may be used “as-isolated” or may be coated or encapsulated as disclosed herein.
- the oxygen permeable particles may be encapsulated prior to incorporation into the reactive mixture used to make the polymer. This is particularly useful when either the core of a solid oxygen permeable particle or an inner layer of a hollow nanostructure is made from a water impermeable material or an amphiphilic material.
- encapsulated means surrounding the oxygen permeable particles with another material or entrapping the oxygen permeable particle within another material. Suitable means of encapsulating include coating the oxygen permeable particles, entrapping the oxygen permeable compounds within another material, to form for example a liposomal, micellar or polymeric structure around the oxygen permeable particles, combinations thereof and the like.
- the oxygen permeable particles may be encapsulated for a number of reasons. For example, oxygen permeable particles may be coated with a polymer to prevent them from causing an immunological response when incorporated into a medical device.
- the oxygen permeable particles may be encapsulated to change the properties of the particles, such as, for example, to make them more compatible with the components of the reactive mixture used to make the polymer.
- the particles may be encapsulated to help maintain a desired particle size, to prevent or limit aggregation or to provide the final article with other desired properties, such as but not limited to refractive index, biocompatibility (including immunological response, protein or lipid uptake), combinations thereof and the like.
- the oxygen permeable particles may be encapsulated within a hydrophilic shell and dispersed within the reactive mixture.
- encapsulation In addition to displaying improved compatibility with a hydrophilic reaction mixture, encapsulation also prevents the formation of hydrophobic sites within a lens formed from said reaction mixture. Hydrophobic sites may cause protein denaturation and lens fouling. Other reasons for encapsulation, and benefits therefrom will be apparent to those of skill in the art.
- the oxygen permeable particles may be dispersed or suspended in the reactive mixture.
- the particles may be dispersed via ionic or steric forces, or a combination thereof.
- oxygen permeable particles form stable dispersions displaying particle sizes of less than about 1000 nm, which remain dispersed for at least about one hour, and in some embodiments at least about one day, and in some embodiments for a week or more.
- the reaction mixture may further comprise at least one surface active agent may be added. Suitable surface active agents are compatible with the reactive mixture and suspended or dispersed particles, and do not cause haze. Suitable surface active agents include small molecule surfactants, polymeric surfactants, amphiphilic copolymers, combinations thereof and the like.
- suitable surface active agents include PEG-120 Methyl Glucose Dioleate (DOE 120, commercially from Lubrizol), PVP, polyvinyl alcohol/polyvinyl acetate copolymers, amphiphilic statitistical or block copolymers such as silicone/PVP block copolymers, polyalkylmethacrylate/hydrophilic block copolymers, organoalkoxysilanes such as 3-aminopropyltriethoxysilane (APS), methyl-triethoxysilane (MTS), phenyl-trimethoxysilane (PTS), vinyl-triethoxysilane (VTS), and 3-glycidoxypropyltrimethoxysilane (GPS), silicone macromers having molecular weights greater than about 10,000 and comprising groups which increase viscosity, such as hydrogen bonding groups, such as but not limited to hydroxyl groups and urethane groups and mixtures thereof.
- DOE 120 Methyl Glu
- the dispersing agent is a polymer
- it can have a range of molecular weights. Molecular weights from about 1000 up to several million may be used. The upper limit is bounded only by the solubility of the dispersing agent in the reactive mixture.
- the dispersing agent may be present in amounts between about 0.001% to about 40 weight %, based upon the weight % of all components in the reactive mixture. In some embodiments the dispersing agent may be present in amounts between about 0.01 weight % and about 30 weight % and in other embodiments between about 0.1 weight % and about 30 weight %. In some embodiments, the dispersing agent is also a reactive component used to form the polymeric article, such as where a contact lens comprising polyvinyl alcohol is produced. In these embodiments the amount of dispersing agent used may be up to about 90 weight % and in some embodiments up to about 100 weight % based upon the weight % of all components in the reactive mixture.
- the oxygen permeable particles are coated with a coating composition.
- suitable coating compositions may be selected to provide any of the features described above.
- suitable coating compositions include anionic, potentially anionic, cationic, potentially cationic, zwitterionic and polar neutral coating compositions, combinations thereof and the like.
- anionic and potentially anionic polymers which may be used as coating materials include, polyacrylic acid, hyaluronic acid, dextran sulfate, alginates, copolymers and mixtures thereof and the like.
- cationic and potentially cationic polymers include poly(diallyldimethylammonium chloride)(PDADMAC), chitosan, poly(quats), poly(amines), poly(pyridines), copolymers and mixtures thereof and the like.
- zwitterionic polymers examples include_poly(sulfobetaines), poly(carboxybetaines), poly(phosphobetaines), copolymers thereof and the like.
- Specific examples of zwitterionic polymers include poly(3-[N-(2-acrylamidoethyl)dimethylammonio]propanesulfonate) poly(3-[N-(2-methylacrylamidoethyl)dimethylammonio]propanesulfonate), poly(3-[N-(2-methacryloxyethyl)dimethylammonio]propanesulfonate, poly(3-(N,N-dimethyl-N-(4-vinyl-phenyl)-ammonio)propanesulfonate, poly(3-[N-(2-acrylamidoethyl)dimethylammonio]propionate), poly(3-[N-(2-methylacrylamidoethyl)dimethylammonio]prop
- Suitable methods for coating include 1) deposition of alternating layers of cationic/anionic polymers, polyacid/polybases, or polymeric hydrogen donor/acceptor species, 2) plasma treatment, 3) divergent and convergent graft (co)polymerization via conventional or controlled radical polymerization, 4) simple chemical modification of the surface with small molecules, such as grafting, or 5) surface degradation by chemical means, i.e. acid/base catalyzed hydrolysis, modification of the particle surface via ion, x-ray, gamma ray, or electron bombardment. Other modifications methods include oxidative plasma treatment and controlled gas plasma deposition.
- the oxygen permeable particles are encapsulated within a micelle.
- routes including but not limited to 1) direct micellization/solubilization of PDMS fluid to form an oil-in-water emulsion or micro-emulsion with a suitable surfactant system, 2) formation of an emulsion/micro-emulsion and subsequent curing of a reactive silicone, where the reactive silicone could consist of, but is not limited to a silanol functional polydialkyl siloxane oligomer, 3) formation of an emulsion or micro-emulsion and subsequent metal-catalyzed curing of reactive silicones, where the reactive silicone could consist of, but is not limited to a mixture of a vinyl- or allyl-functional polydialkyl siloxane oligomer and a hydride functional polydialkyl siloxane oligomer, and 4) preparation of siloxy-containing latexes via emulsion or micro-emulsion free radical polymerization
- siloxy-emulsions/micro-emulsions may also be prepared directly in a reactive monomer mixture with appropriate monomer and diluent selection.
- Particles formed via the above-mentioned emulsion/micro-emulsion processes can be further stabilized by incorporation of a cross-linking agent during the curing process. Selection of cross-linking agents depends on the functionality of the reactive-silicone employed in particle formation.
- silicone cross-linking agents are well known to those skilled in the art and include, but are not limited to SiMAA DM (Methyl-bis(trimethylsilyloxy)-silyl-propylglycerol-dimethacrylate), tetra-alkoxy silanes and poly-functional vinyl, allyl, or silyl-hydride moieties with appropriate hydrosilylating metal catalysts.
- SiMAA DM Metal-bis(trimethylsilyloxy)-silyl-propylglycerol-dimethacrylate
- tetra-alkoxy silanes and poly-functional vinyl, allyl, or silyl-hydride moieties with appropriate hydrosilylating metal catalysts.
- Siloxy-emulsions/micro-emulsions may be formed from a variety of surfactant systems, including both ionic and non-ionic detergents.
- Surfactants that are commonly used in the preparation of latexes may be employed and are obvious to those skilled in the art. Examples of said surfactants include, but are not limited to alkyl sulfates, alkyl sulfonates, alkylbenzene sulfonates, fatty acids, alkyl ethoxylates, alkyl quaternary ammonium salts, alkyl glucocides, polysorbates, and all combinations thereof.
- Reactive surfactants may also be employed in the preparation of silicone microemulsion systems. Also known in the literature as “surfiners,” these surface-active compounds contain a reactive group at the hydrophobic or hydrophilic terminus and are capable of taking part in the polymerization process, thereby incorporating themselves into final polymeric particle and eliminating or minimizing the need for surfactant removal. Examples of such materials that may be used to form silicone microemulsion particles include but are not limited to allyl polyalkylene glycol ethers, vinyl polyalkylene glycol ethers, allyl polyalkylene glycol ether sulfates, methacrylic acid esters of alkyl polyethylene glycol ethers, and vinyl polyethylene glycol ethers. These agents may be used as a substitute for or in combination with the above-mentioned standard emulsion polymerization surfactants.
- polymeric surfactants and emulsifying agents may also be used in the preparation of siloxy-emulsions/micro-emulsions.
- polymeric surfactants are well-known to those skilled in the art and include, but are not limited to pluronic/polaxamer surfactants, (co)polymers of N-vinyl pyrrolidone, copolymers of various hydrophobic monomers with vinyl alcohol, poly(ethylene-co-maleic anhydride) and combinations there of.
- vinyl siloxy macromers such as, but not limited to SiMAA2 DM, OHmPDMS, and/or mPDMS, or combinations thereof, allow for the facile synthesis of high Dk particles with tunable compositions, and consequently, controlled structures and properties.
- this embodiment involves a micro-emulsion composed of one or a combination of the above-mentioned surfactants in water, at least one siloxy macromer, a cross-linking reactive monomer (such as SiMAA2 DM, EGDMA (ethylene glycol dimethacrylate) or DVB (divinylbenzene)), and a water-soluble free radical initiator.
- a cross-linking reactive monomer such as SiMAA2 DM, EGDMA (ethylene glycol dimethacrylate) or DVB (divinylbenzene)
- the polymerization may be initiated via thermal, photochemical, or redox pathways.
- the ratio of OHmPDMS to SiMAA2 DM may be varied to obtain final particles with tailored physical properties, including but not limited to desirable refractive index values and increased particle stability.
- water-soluble free radical initiator is defined as any compound that, under specific conditions (i.e. temperature, light intensity and wavelength), generates one or multiple active radical species. These compounds are well known to those skilled in the art. Examples of water-soluble free radical initiators that may be employed within this embodiment include but are not limited to VA-044 (2,2′-Azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride), V-50 (2,2′-Azobis(2-methylpropionamidine)dihydrochloride), VA-057 (2,2′-Azobis[N-(2-carboxyethyl)-2-methylpropionamidine]hydrate, VA-060 (2,2′-Azobis ⁇ 2-[1-(2-hydroxyethyl)-2-imidazolin-2-yl]propane ⁇ dihydrochloride), VA-061 (2,2′-Azobis[2-(2-imidazolin-2-yl)
- the choice of water-soluble free radical initiator may dictate the final properties of the particles generated by emulsion/micro-emulsion polymerization.
- the surface properties of the final siloxy-latex may be modified, leading to controlled surface features, such as but not limited to, increased surface polarity, hydrophilicity, and consequently, biocompatibility.
- the oxygen permeable polymeric particles may covalently bond to, may associate with, or may be physically entrapped within their stabilizing surfactants.
- the particles may have a core/shell structure, containing the high Dk material in the core and the stabilizing surfactants and other stabilizing moieties in the shell.
- the micelle may covalently bond to the hydrogel polymer, may associate with the hydrogel polymer, or may be physically entrapped within the hydrogel polymer.
- the micelle may have a core/shell structure. Suitable compositions for forming micellar coatings may be selected to provide any of the features described above.
- suitable micelle compositions include that yield in the final particle, an anionic, cationic, zwitterionic, or polar-neutral micelle surface.
- Such moieties on the surface of micelle particles can be introduced by employing a silicone-reactive capping agent or surfactant during the emulsion/micro-emulsion process.
- any of the anionic, cationic or zwitterionic polymers disclosed above as coating compounds may be used in forming micellar coatings, so long as one end comprises the cationic, zwitterionic or anionic groups disclosed above, and the other end is compatible with said oxygen permeable particle.
- moieties which may be included at the hydrophobic terminus include alkoxy silanes, polychloro-silanes, vinyl silanes, polyfunctional allyl moieties, and polsilyl-hydrides, etc.), an aliphatic linker (typically propyl or butyl), and the like.
- Monomers and oligomers may also be used to form the micellar coatings of the present invention.
- alkyl benzene sulfonate and alkyl ethoxylate made by the methods described in IN 2003KO00640 by Wacker Metroark Chemicals Ltd.
- Other patents involving silicone ME polymerizations include U.S. Pat. No. 5,661,215, and U.S. Pat. No. 6,316,541.
- Suitable methods for forming a micellar coating include those that yield in the final particle, an anionic, cationic, zwitterionic, or polar-neutral surface.
- Such moieties on the surface of micelle particles can be introduced by employing a silicone-reactive capping agent or surfactant during the emulsion process.
- the capping agents are also surface-active and include a hydrophobic silicone-reactive moiety at one terminus (including, but not limited to alkoxy silanes, polychloro-silanes, vinyl silanes, polyfunctional allyl moieties, and polsilyl-hydrides, etc.), an aliphatic linker (typically propyl or butyl), and the desired polar or ionic group at the other terminus.
- the surface chemistry of the micelle particles can be easily manipulated by appropriate selection of capping agent in combinations thereof and the like.
- an emulsion is formed by mixing the selected surfactant in a suitable solvent above the critical micelle concentration, and preferably in concentrations greater than about 10 weight % and in some embodiments between about 15 and about 25 weight % surfactant, and in some embodiments between about 15 to about 20 weight %.
- a suitable solvent above the critical micelle concentration, and preferably in concentrations greater than about 10 weight % and in some embodiments between about 15 and about 25 weight % surfactant, and in some embodiments between about 15 to about 20 weight %.
- microemulsions may also be formed depending upon the particles and surfactants selected.
- the emulsion is heated and the oxygen permeable particles added.
- crosslinking agents may be added to form crosslinked micelles.
- the oxygen permeable particles are encapsulated into liposomes.
- Suitable compositions may be selected to provide any of the features described above.
- phospholipids and other liposome-forming compounds may be employed.
- Suitable liposome forming compounds may include, but are not limited to DSPC (distearoylphosphatidylcholine), HSPC (hydrogentated soy phosphatidylcholine), and poly(ethylene glycol) conjugates with cholesterol, lipids, and phospholipids, combinations thereof, and the like.
- Suitable methods for forming liposomes include known methods, such as but not limited to mixing the desired components, sonication, membrane extrusion and the like.
- encapsulated solid oxygen permeable particles examples include cross-linked poly(dimethylsiloxane) core and a poly(silsesquioxane) shell prepared by Shin Etsu, Inc. (Japan) sold as X-52-7030, and having an average size distribution of 800 nm with a range from 0.2-2000 nm, dimethicone/vinyl dimethicone crosspolymer with silica treated coating, sold by Dow Corning as 9701 Cosmetic Powder.
- the oxygen permeable particles may be incorporated into the hydrogel polymers of the present invention in an oxygen permeable enhancing effective amount.
- an “oxygen permeable enhancing effective amount” is an amount effective to increase the oxygen permeability of the polymer by at least about 10%, at least about 25%, and in some embodiments at least about 50%, and in other embodiments, greater than 100%, compared to the oxygen permeability of the hydrogel polymer having no oxygen permeable particles.
- the compositions of the present invention comprise oxygen permeabilities of at least 25 barrer, at least about 40 barrers, in some embodiments at least about 60 barrers, and in other embodiments at least about 80 barrers and in other embodiments at least about 100 barrers.
- the amount of oxygen permeable particles to be added to a reactive mixture can be readily determined by the desired oxygen permeability for the composition and the oxygen permeability for the polymer without any oxygen permeable particles. This may be readily done by making films of the polymers having different concentrations of the oxygen permeable particles, measuring the Dk of the films and interpolating to the desired oxygen permeability target to a concentration for the oxygen permeable particles of 100%.
- the amount of nanostructures to be added to a reactive mixture can be readily determined by the target oxygen permeability of the system utilizing known permeability theory as described in Journal of Biotechnology 77 (2000) 151-156 “Evaluation of oxygen permeability of gas vesicles from cyanobacterium Anabaena flos-aquae”.
- the oxygen permeability of the encapsulated oxygen permeable particles will be dependent upon the properties of both the oxygen permeable particle and the encapsulating material, including, but not limited to particle size, surface area of the encapsulated particle, surface composition, thickness of the encapsulating material, degree of cross-linking in the core and shell.
- the hydrogel polymer is a copolymer hydroxyethyl methacrylate (HEMA) and about 2 weight % methacrylic acid (MAA), (which has an oxygen permeability of about 20 barrers), and the particles of PDMS (which has an oxygen permeability of about 600 barrers) are used as the oxygen permeable particle
- the oxygen permeable particles may be added in amounts of at least about 15 weight %, and in some embodiments between about 20 and about 70 weight %.
- the oxygen permeable particles may be added in amounts which are insufficient to undesirably impact other properties of the resulting composition.
- the polymer should be free from visible haze at the desired thickness of the article.
- the polymer displays a % haze of less about 15%, in some embodiments less about 10%, and in others less than about 5% using the method described below.
- the article is a contact lens, and the oxygen permeable particles are primarily incorporated outside the optic zone. This allows loadings of particles which have particles, particle concentrations or both which cause haze in the resulting lens.
- the oxygen permeable particles may be added to the reactive mixtures used to make conventional hydrogels.
- Conventional hydrogels are well known and include homo and copolymers of polyHEMA and polyvinyl alcohol. Suitable comonomers include methacrylic acid, N-vinylpyrrolidone, N-vinyl acetamide, N-vinyl methyl acetamide, N,N dimethyl acrylamide, acrylic acid, glycerol monomethacrylate, MPC (2-Methacryloyloxyethyl phosphorylcholine)), methyl methacrylate, hydroxyethyl acrylate, N-(1,1-dimethyl-3-oxybutyl)acrylamide, polyethylene glycol monomethacrylate, polyethylene glycol dimethacrylate, 2-ethoxyethyl methacrylate, 2-methacryloxyethyl phosphorylcholine combinations thereof and the like.
- Homo and copolymers of polyHEMA include etafilcon, polymacon, vifilcon, bufilcon, crofilcon, genfilcon, hioxifilcon, lenefilcon, methafilcon, ocufilcon, perfilcon, surfilcon, tetrafilcon.
- Homo and copolymers of polyvinyl alcohol may also be used, including atlafilcon, and nelfilcon.
- Homo and copolymers of methyl methacrylate and hydrophilic monomers such as N,N-dimethyl methacrylamide or N-vinyl pyrrolidone, such as lidofilcon, may also be used.
- the oxygen permeable particles may be used to increase the oxygen permeability of any hydrogel formulation, including silicone hydrogels such as but not limited to balafilcon, lotrafilcon, aquafilcon, senofilcon, galyfilcon, narafilcon, comfilcon, oxyfilcon, siloxyfilcon and the like.
- silicone hydrogels such as but not limited to balafilcon, lotrafilcon, aquafilcon, senofilcon, galyfilcon, narafilcon, comfilcon, oxyfilcon, siloxyfilcon and the like.
- balafilcon such as but not limited to balafilcon, lotrafilcon, aquafilcon, senofilcon, galyfilcon, narafilcon, comfilcon, oxyfilcon, siloxyfilcon and the like.
- lotrafilcon includes both lotrafilcon A and B.
- the oxygen permeable particles of the present invention may be added directly to the reaction mixture used to form the hydrogel polymer or may be soaked or imbibed into the hydrogel polymer post cure.
- the reactive components and oxygen permeable particles are mixed together to form the reactive mixture.
- the reactive mixture may optionally include diluents to help with processing or provide improved compatibility.
- Suitable diluents are known in art and may be selected based upon the polymer which is selected.
- suitable diluents for conventional hydrogels include organic solvents, water or mixtures hereof.
- organic solvents such as alcohols, diols, triols, polyols and polyalkylene glycols may be used. Examples include but are not limited to glycerin, diols such as ethylene glycol or diethylene glycol; boris acid esters of polyols such as those described in U.S.
- Diluents can also be selected from the group having a combination of a defined viscosity and Hanson cohesion parameter as described in U.S. Pat. No. 4,680,336.
- cross-linking agents also referred to as cross-linking monomers
- EGDMA ethylene glycol dimethacrylate
- TMPTMA trimethylolpropane trimethacrylate
- glycerol trimethacrylate polyethylene glycol dimethacrylate (wherein the polyethylene glycol preferably has a molecular weight up to, e.g., about 5000)
- other polyacrylate and polymethacrylate esters such as the end-capped polyoxyethylene polyols described above containing two or more terminal methacrylate moieties.
- cross-linking agents are used in the usual amounts, e.g., up to about 2 weight % of reactive components in the reaction mixture.
- the addition of a separate crosslinking agent to the reaction mixture is optional.
- hydrophilic monomers that can act as the crosslinking agent and when present do not require the addition of an additional crosslinking agent to the reaction mixture include polyoxyethylene polyols containing two or more terminal methacrylate moieties.
- the reactive mixture may contain additional components such as, but not limited to, UV absorbers, medicinal agents, antimicrobial compounds, reactive tints, pigments, copolymerizable and nonpolymerizable dyes, release agents and combinations thereof.
- a polymerization initiator may also be included in the reaction mixture.
- Polymerization initiators include compounds such as lauryl peroxide, benzoyl peroxide, isopropyl percarbonate, azobisisobutyronitrile, and the like, that generate free radicals at moderately elevated temperatures, and photoinitiator systems such as aromatic alpha-hydroxy ketones, alkoxyoxybenzoins, acetophenones, acylphosphine oxides, bisacylphosphine oxides, and a tertiary amine plus a diketone, mixtures thereof and the like.
- Photoinitiators are 1-hydroxycyclohexyl phenyl ketone, 2-hydroxy-2-methyl-1-phenyl-propan-1-one, bis(2,6-dimethoxybenzoyl)-2,4-4-trimethylpentyl phosphine oxide (DMBAPO), bis(2,4,6-trimethylbenzoyl)-phenyl phosphineoxide (Irgacure 819), 2,4,6-trimethylbenzyldiphenyl phosphine oxide and 2,4,6-trimethylbenzoyl diphenylphosphine oxide, benzoin methyl ester and a combination of camphorquinone and ethyl 4-(N,N-dimethylamino)benzoate.
- DMBAPO bis(2,6-dimethoxybenzoyl)-2,4-4-trimethylpentyl phosphine oxide
- Irgacure 819 bis(2,4,6-trimethylbenzoyl)-phenyl
- UV photoinitiators include Darocur 1173 and Darocur 2959 (Ciba Specialty Chemicals). These and other photoinitiators which may be used are disclosed in Volume III, Photoinitiators for Free Radical Cationic & Anionic Photopolymerization, 2 nd Edition by J. V. Crivello & K. Dietliker; edited by G.
- the initiator is used in the reaction mixture in effective amounts to initiate photopolymerization of the reaction mixture, e.g., from about 0.1 to about 2 parts by weight per 100 parts of reactive monomer.
- Polymerization of the reaction mixture can be initiated using the appropriate choice of heat or visible or ultraviolet light or other means depending on the polymerization initiator used. Alternatively, initiation can be conducted without a photoinitiator using, for example, e-beam.
- preferred initiators induce bisacylphosphine oxides, such as bis(2,4,6-trimethylbenzoyl)-phenyl phosphine oxide (Irgacure 819®) or a combination of 1-hydroxycyclohexyl phenyl ketone and bis(2,6-dimethoxybenzoyl)-2,4-4-trimethylpentyl phosphine oxide (DMBAPO), and a preferred method of polymerization initiation is visible light.
- a preferred is bis(2,4,6-trimethylbenzoyl)-phenyl phosphine oxide (Irgacure 819®).
- Articles such as biomedical devices, and in some embodiments ophthalmic devices, may be prepared by mixing reactive components and the diluent(s), if used, with a polymerization initiator and curing by appropriate conditions to form a product that can be subsequently formed into the appropriate shape by lathing, cutting and the like.
- the reaction mixture may be placed in a mold having the shape of the desired article and subsequently cured into the desired article.
- any of the known processes for curing the reaction mixture in the production of contact lenses may be used.
- Spincasting methods are disclosed in U.S. Pat. Nos. 3,408,429 and 3,660,545, and static casting methods are disclosed in U.S. Pat. Nos. 4,113,224 and 4,197,266.
- the method for producing contact lenses comprising the polymer of this invention is by the direct molding of the reaction mixture, which is economical, and enables precise control over the final shape of the hydrated lens.
- the reaction mixture is placed in a mold having the shape of the final desired lens, and the reaction mixture is subjected to conditions whereby the reactive components polymerize, to thereby produce a polymer/diluent mixture in the shape of the final desired lens.
- compositions of the present invention have a balance of properties which makes them particularly useful.
- properties include clarity, water content, oxygen permeability and contact angle.
- the biomedical devices are contact lenses having a water content of greater than about 20%, and in some embodiments greater than about 30%.
- clarity means substantially free from visible haze.
- Clear lenses have a haze value of less than about 150%, more preferably less than about 100% compared to a CSI lens.
- hydrogels as the polymer provides additional benefits to resulting articles such as contact lenses, including contact angles below about 100°, and modulus below about 100 psi.
- contact lenses formed from the compositions of the present invention have average contact angles (advancing) which are less than about 80°, less than about 75° and in some embodiments less than about 70°.
- the articles of the present invention have combinations of the above described oxygen permeability, water content and contact angle. All combinations of the above ranges are deemed to be within the present invention.
- clarity means substantially free from visible haze. Clarity may be measured via % haze which is calculated from transmittance. Transmittance may be measured via ASTM D1003 using an integrating sphere hazemeter. The test is conducted by taking four different consecutive readings and measuring the photocell output as follows
- T 1 specimen and light trap out of position
- reflectance standard in position T 2 specimen and reflectance standard in position
- light trap out of position T 3 light trap in position
- specimen and reflectance standard out of position T 4 specimen and light trap in position, reflectance standard out of position
- Total transmittance T t and diffuse transmittance T d are calculated as follows
- T d [T 4 ⁇ T 3 ( T 2 /T 1 )]/ T 1
- the water content of contact lenses was measured as follows: Three sets of three lenses are allowed to sit in packing solution for 24 hours. Each lens is blotted with damp wipes and weighed. The lenses are dried at 60° C. for four hours at a pressure of 0.4 inches Hg or less. The dried lenses are weighed. The water content is calculated as follows:
- the average and standard deviation of the water content are calculated for the samples and are reported.
- Modulus is measured by using the crosshead of a constant rate of movement type tensile testing machine equipped with a load cell that is lowered to the initial gauge height.
- a suitable testing machine includes an Instron model 1122.
- a dog-bone shaped sample from ⁇ 1.00 lenses having a 0.522 inch length, 0.276 inch “ear” width and 0.213 inch “neck” width is loaded into the grips and elongated at a constant rate of strain of 2 in/min. until it breaks.
- Tensile modulus is measured at the initial linear portion of the stress/strain curve.
- the advancing contact angle was measured using ⁇ 1.00 power lenses as follows. Four samples from each set were prepared by cutting out a center strip from the lens approximately 5 mm in width and equilibrated in packing solution. The wetting force between the lens surface and borate buffered saline is measured at 23° C. using a Wilhelmy microbalance while the sample is being immersed into or pulled out of the saline. The following equation is used
- F is the wetting force
- ⁇ is the surface tension of the probe liquid
- p is the perimeter of the sample at the meniscus
- ⁇ is the contact angle.
- the advancing contact angle is obtained from the portion of the wetting experiment where the sample is being immersed into the packing solution. Each sample was cycled four times and the results were averaged to obtain the advancing contact angles for the lens.
- the Dk is measured as follows. Lenses are positioned on a polarographic oxygen sensor consisting of a 4 mm diameter gold cathode and a silver ring anode then covered on the upper side with a mesh support. The lens is exposed to an atmosphere of humidified 2.1% O 2 . The oxygen that diffuses through the lens is measured by the sensor. Lenses are either stacked on top of each other to increase the thickness or a thicker lens is used. The L/Dk of 4 samples with significantly different thickness values are measured and plotted against the thickness. The inverse of the regressed slope is the Dk of the sample. The reference values are those measured on commercially available contact lenses using this method.
- Balafilcon A lenses ( ⁇ 1.00) available from Bausch & Lomb give a measurement of approx. 79 barrer.
- NIST SRM 1066a Octaphenylcyclotetrasiloxane is co-analyzed with the samples as a quality control check for the analysis.
- the certified silicon concentration in this SRM is 14.14 ⁇ 0.07 Wt. % Si.
- the average value for the analysis of three 10 mg aliquots of the SRM was 14.63 ⁇ 0.70 Wt. % Si.
- SEM Surface characterization Surface images were captured from all samples on both the concave and convex surfaces at three locations (left, middle and right). The imaging was performed using an FEI Quanta Environmental SEM using an accelerating voltage of 25 kV and 5 nA of beam current at 5000 ⁇ magnification for all locations in SE and BSE imaging modes.
- Profile (cross-section) images were captured using the same beam conditions as the surface images. Since the entire cross section of the lens could not be imaged at 5 k ⁇ magnification creating mosaics of the images was necessary to view the entire cross-section of each lens. Images were captured in serial at 5 k ⁇ magnification starting near the concave side of the lens (top), then stepped frame by frame through the lens until the convex edge of the lens was eventually imaged. The individual images were then merged together using Photoshop.
- Monomer mix comprising 94.90% HEMA, 1.94% MAA, 0.95% Norbloc, 1.33% Irgacure 1700, 0.77% EGDMA, 0.09% TMPTMA, and 0.02% Blue HEMA (w/w) in BAGE diluent (52:48 monomer:diluent) herein referred to as reactive monomer mix (RMM) was prepared and used for Examples 1-11.
- RRM reactive monomer mix
- examples 1-10 In the preparation of examples 1-10 the desired mass of Si microparticles was added to an amber scintillation vial followed by addition of etafilcon RMM (10 g). The scintillation vial was capped and rolled for 2 hours prior to being degassed in vacuo (10 minutes) and used to prepare lenses. Levels of microparticles and RMM employed for each formulation are listed in Table 1, below. Lenses were then prepared for each example by dosing each Si microparticl monomer mix into separate front curves via pipette.
- Example 11 in Table 1 was prepared by suspending half of the mass of the microparticles required in 2.4 g ethylene glycol and the other half in 5.2 g of monomer mix without BAGE. The mixture was then further diluted with BAGE and homogenized via high-shear mechanical mixing. The resulting monomer mix was degassed for 10 minutes in vacuo. The high viscosity of Example 11 required that it be dosed into the front-curves via a pressurized syringe.
- All lenses were prepared at ⁇ 1.0 power using Zeonor (Zeon Chemical) front/back curves. Curing was carried-out in an N 2 -purged glove box at 50° C. for 10 minutes under a TL03 lamp (400 nm) at an intensity of 3.4 mW/cm 2 . Lenses were demolded and released in a deionized water-bath at 90° C. prior to being stored in Borate Buffered Saline Solution in individual crimp-sealed, glass vials. All lenses were sterilized at 121° C. for 30 minutes in an autoclave prior to analysis.
- the Dk, water-content, and Si content were measured for each set of lenses.
- FIG. 1 is a graph of Dk versus silicone microparticle concentration in the final lens.
- FIG. 1 shows a positive, non-linear polynomial trend.
- An SEM micrograph of the lens of Example 10 is shown at FIG. 3 . All locations imaged by SEM had very rough surfaces containing many clusters of particles. Generally the topography and particle clustering was homogenous throughout the sample (on both sides of the lenses). Individual particle sizes were not able to be measured due to the clustering of the particles. Through observation of SEM images the particles were estimated to be between about 600 and about 1000 nm in size.
- the SEM cross-sections of the lenses looked nearly homogenous to that of the surface images, consisting of clustered particles resulting in a rough topography.
- Water-soluble initiator was purchased from Wako Specialty Chemical Company and was also used as received.
- Each of the particle dispersions having the compositions listed in Table 3, were made as follows. Water and DBS were added to a 1 L, 3-necked, jacketed reaction flask, equipped with a mechanical stirrer and thermal probe. The water and DBS were heated to 44° C. and stirred under a nitrogen blanket until a transparent microemulsion was formed. After 30 minutes of stirring at 300 rpm under nitrogen, an aqueous VA-044 solution (200 mg in 1 mL DI water) was added by syringe and allowed to mix. Both OHmPDMS and SiMAA DM were blended together and the resulting mixture was added drop-wise to the microemulsion while stirring at 300 rpm.
- the addition funnel was removed and the flask was sealed with a vented rubber septum. The reaction was kept under a nitrogen atmosphere at 44° C. overnight. The following morning, an additional 200 mg VA-044 in 1 mL DI water was added to the microemulsion. The microemulsion was then allowed to react for an additional four hours.
- Each dispersion listed in Table 3 was characterized via dynamic light scattering (DLS) with a Malvern-ZetaSizer Nano-S detector. After each reaction was complete, an aliquot was removed and diluted 10-fold. The diluted dispersion was then analyzed by DLS to obtain the z-average particle size distribution. Measurements were also taken after dialysis of each dispersion. Data files from the DLS were processes using CUMULANTS analysis function included in the detector software. All data files generated good fits within the CUMULANTS curve. The hydrodynamic diameters of each resulting Silicone ME are listed in Table 4 below with their corresponding PDI widths and % PDI values.
- the dispersions are stable in water for at least 2 months. Any settling is readily redispersed with mild agitation.
- Dispersions having 50:50 HO-mPDMS and SiMAA DM in water were made as above. This dispersion was dialyzed against DI water using a 3500 MWCO regenerated cellulose dialysis membrane from Spectrapore. The resulting dispersion was stable for over 2 months.
- Frequency histograms of the Examples 12-15 are attached.
- the data files generated from DLS of Examples 12-15 correlated well using CUMULANTS fit, indicating Gaussian distribution of particle size and evidencing low or no aggregation in the dispersions. This is shown graphically by the histograms shown in FIGS. 4-7 .
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- General Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Eyeglasses (AREA)
- Materials For Medical Uses (AREA)
Abstract
The present invention relates to a composition comprising a hydrogel polymer having less than 100% haze, and distributed therein an oxygen enhancing effective amount of oxygen permeable particles having an oxygen permeability of at least about 100 barrer, average particle size less than about 5000 nm.
Description
- This application claims priority of U.S. Provisional Patent Application No. 61/164,931 filed Mar. 31, 2009 and U.S. Provisional Patent Application No. 61/252,279 filed Oct. 16, 2009.
- The invention relates to polymeric articles comprising oxygen permeability enhancing particles and processes for forming such articles.
- Polymeric materials displaying oxygen permeability are desirable for a number of applications, including medical devices. One such application is contact lenses.
- Gas permeable soft contact lenses (“GPSCL”) have been made from conventional and silicone hydrogels. Conventional hydrogels have been prepared from monomeric mixtures predominantly containing hydrophilic monomers, such as 2-hydroxyethyl methacrylate (“HEMA”), N-vinyl pyrrolidone (“NVP”) and vinyl alcohol. The oxygen permeability of these conventional hydrogel materials relates to the water content of the materials, and is typically below about 20-30 barrers. For contact lenses made of the conventional hydrogel materials, that level of oxygen permeability is suitable for short-term wear of the contact lenses; however, that level of oxygen permeability may be insufficient to maintain a healthy cornea during long-term wear of contact lenses (e.g., 30 days without removal).
- Silicone hydrogels (SiH's) are also currently used as materials in GPSCLs. Silicone hydrogels have typically been prepared by polymerizing mixtures containing at least one silicone-containing monomer or reactive macromer and at least one hydrophilic monomer. While this class of lens material reduces the corneal edema and hyper-vasculature associated with conventional hydrogel lenses, they can be difficult to produce because the silicone components and the hydrophilic components are incompatible. Additional material improvements to protein uptake profiles, wettability and general comfort on the eye over extended periods of time are also desirable.
- Silicone elastomer contact lenses have also been made. These lenses displayed good oxygen permeability, but had poor wettability and mechanical properties. Reinforced silica filler has been disclosed as improving the physical properties of the silicone elastomers.
- The present invention relates to a composition comprising a polymer having distributed therein an oxygen enhancing effective amount of oxygen permeable particles having an oxygen permeability of at least about 100 barrer and an average particle size less than about 5000 nm.
-
FIG. 1 is a graph of Dk vs. concentration of silicon microparticles in the polymer. -
FIG. 2 is a graph of Dk vs. silicon content. -
FIG. 3 is an SEM micrograph of an etafilcon-based lens containing 800 nm Shin Etsu POSS/PDMS micro-particles -
FIG. 4 is the Volume Distribution Histogram of Particle Sizes for SiME-OHmPDMS 20 -
FIG. 5 is the Volume Distribution Histogram of Particle Sizes for SiME-OHmPDMS 40 -
FIG. 6 is the Volume Distribution Histogram of Particle Sizes for SiME-OHmPDMS 60 -
FIG. 7 is the Volume Distribution Histogram of Particle Sizes for SiME-OHmPDMS 80 - As used herein, a “medical device” is any article that is designed to be used while either in or on mammalian tissues or fluid. Examples of these devices include but are not limited to catheters, implants, stents, and ophthalmic devices such as intraocular lenses and contact lenses. The preferred biomedical devices are ophthalmic devices, particularly contact lenses, most particularly contact lenses made from hydrogels.
- As used herein, the term “lens” refers to ophthalmic devices that reside in or on the eye. These devices can provide optical correction, cosmetic enhancement, radiation reduction, including UV blocking and visible light or glare reduction, therapeutic effect, including wound healing, delivery of drugs or nutraceuticals, diagnostic evaluation or monitoring, or any combination thereof. The term lens includes, but is not limited to, soft contact lenses, hard contact lenses, intraocular lenses, overlay lenses, ocular inserts, and optical inserts.
- A “reaction mixture” is the mixture of components, including, reactive components, diluent (if used), initiators, crosslinkers and additives, which when subjected to polymer forming conditions form a polymer.
- Reactive components are the components in the reaction mixture, which upon polymerization, become a permanent part of the polymer, either via chemical bonding, entrapment or entanglement within the polymer matrix. For example, reactive monomers become part of the polymer via polymerization, while non-reactive polymeric internal wetting agents, such as PVP, and the oxygen permeable particles of the present invention, became part of the polymer via physical entrapment. The diluent (if used) and any additional processing aids, such as deblocking agents do not become part of the structure of the polymer and are not part of the reactive components. The reaction mixtures of the present invention can be formed by any of the methods known by those skilled in the art to be useful to form polymeric articles or devices, and include stirring, rolling, kneading and shaking.
- As used herein “biocompatibility” and “biocompatible” means that the material in question does not cause any substantial negative response when in contact with the desired biological system. For example when the oxygen permeable particles are incorporated into contact lenses the undesirable negative responses include stinging, inflammation, undesirable levels of protein and lipid uptake, ocular cell damage and other immunological responses.
- A “hydrogel” polymer is a polymer capable of absorbing or imbibing at least about 20 weight % water, in some embodiments at least about 30 weight % water and in other embodiments at least about 40 weight % water.
- Oxygen permeable particles have an oxygen permeability of at least about 100 barrer, in some embodiments between about 100 and about 1000 barrer, and in other embodiments between about 300 and about 1000 barrers. The oxygen permeable particles may also have oxygen permeabilities of at least about 300, 400 or 500 barrers. The oxygen permeable particles of the present invention may be solid, or “filled” or may be hollow. Solid oxygen permeable particles may be formed from crosslinked polymers, for example, fluorine containing polymers, polydialkylsiloxane polymers, self-assembled siloxanes and rigid materials such as polytrimethylsilylpropyne and combinations thereof.
- In one embodiment the oxygen permeable particles are non-reactive means that under the conditions of formation and use of the compositions of the present invention, the oxygen permeable particles do not covalently bond to the polymer but may associate with the polymer via dipole-dipole forces such as hydrogen bond or van der Waals forces. If the oxygen permeable particles are encapsulated, either the oxygen permeable particles do not covalently bond to the encapsulating material, the encapsulating material does not bond to the polymer or both. In one embodiment the oxygen permeable particles are surface reactive to assist in dispersing and/or stabilizing the oxygen permeable particles in the selected reaction mixtures.
- Potentially anionic or cationic means that the molecule has latent ionicity. An example of a potentially anionic group is a carboxylate, and an example of a potentially cationic group is an amine, and particularly a tertiary amine
- The oxygen permeable particles are selected so that they do not substantially degrade the optical properties of the polymer, including color and clarity. This may be accomplished by controlling the particle size, refractive index, chemical properties of the oxygen permeable particles or any combination of the foregoing. The oxygen permeable particles have a refractive index of within about 20% hydrated polymer matrix and in some embodiments within about 10% of the refractive index of the hydrated polymer matrix. Other embodiments may employ oxygen permeable particles with a refractive index within about 1% of the hydrated polymer matrix and in other embodiments still, less than 0.5%. In one embodiment, the oxygen permeable particles have an average particle size between about 200 and about 1000 nm and a refractive index within about 10% of the refractive index of the hydrated polymer matrix. Oxygen permeable particles with a particle size of less than 200 nm, may have refractive indices which are within about 20% of the refractive index of said hydrated polymer matrix. In one embodiment, where the polymer is a hydrogel suitable for making contact lenses, the refractive index of the oxygen permeable particle is between about 1.37 and about 1.45. In one embodiment the refractive index of the hydrogel polymer is between about 1.39 and about 1.43 and the encapsulated oxygen permeable particles have a refractive index within the ranges specified above.
- In one embodiment, the oxygen permeable particles are incorporated into the ophthalmic devices, and in one embodiment contact lenses in at least one region outside the optic zone. The opic zone is the region through which light is focused. In this embodiment larger particle sizes can be tolerated without refractive index matching. Thus, contact lenses made according to this embodiment may have average particle sizes of between about 200 nm and 100 microns.
- Solid oxygen permeable particles may be formed from materials including cross-linked polymers containing silicones, fluorine, and combinations thereof, oxygen permeable perovskite oxides, combinations thereof and the like. Specific examples of silicone containing polymers include polydimethylsiloxane (PDMS), cross-linked poly(dimethylsiloxane), poly((trimethyl silyl)propyne) and cross-linked poly(dimethylsiloxane) core and a polydimethylsiloxane/and a poly(silsesquioxane) (PDMS/POSS) core/shell shell available from Shin Etsu, Inc. (Japan) under the name X-52-7030, and having an average size distribution of 800 nm with a range from 0.2-2000 nm. Examples of fluorine containing polymers include amorphous fluoropolymers such as 2,2-bis(trifluoromethyl)-4,5-difluoro-1,3-dioxole copolymers with tetrafluoroethylene (sold under the tradename TEFLON AF), fluorinated PDMS, and fluorinated polynorbornene. Copolymers and mixtures containing the foregoing may also be used, so long as the oxygen permeable particles have oxygen permeabilities in the ranges disclosed herein. In one embodiment, the solid oxygen permeable particle comprises at least one inorganic material, such as metalloids such as boron nitrides, metal oxides, including iron oxide, aluminum oxide, titanium dioxide, zirconium oxide, metals, such as gold, transition metal sulfides, such as ZnS and CdS, graphene, inorganic/organic hybrids such as whole shell metal oxides coated with cellulose, Copolymers containing the foregoing and mixtures of any of the foregoing with any of the inorganic materials may also be used.
- Suitable solid oxygen permeable particles have an average particle size less than 5000 nm, in some embodiments less than about 1000 nm, in some embodiments less than about 800 nm, in other embodiments less than about 600 nm and in other embodiments still, less than about 200 nm.
- Alternatively, the oxygen permeable particles may be hollow. Suitable hollow nanostructures have a rigid shell which is impermeable to water and which encapsulates or encloses a gas-filled space. Hollow nanostructures are permeable to gases such as oxygen and air, and have an oxygen permeability of at least about 200 barrer, in some embodiments at least about 300 barrer, in some embodiments at least about 500 barrer, and in other embodiments greater than about 1000 barrers. The hollow nanostructures of the present invention are known by different names including nanostructures, nanoballoons, microcapsules, gas vesicles and microspheres. Any of these known nanostructures may be used, so long as they possess the characteristics described herein. Suitable nanostructures include synthetic hollow nanostructures and gas vesicles. Gas vesicles (or gas vesicle proteins) are naturally found in bacteria and have protein shells which enclose a gas filled space. Synthetic nanostructures comprise shells formed from polymers, metal oxides, metalloids, carbon and combinations thereof.
- When the oxygen permeable particle is a hollow nanostructure, the hollow nanostructures have a particle size, in the longest dimension, of less than 500, in some embodiments less than about 400 nm and in other embodiments still, between about 10 and about 100 nm. In one embodiment the hollow nanostructure have an average diameter of about 20 to about 100 nm and a length of about 100 to about 500 nm. The nanostructures may have any closed, hollow structure, including cylindrical with closed ends, spherical, ovoid, regular and irregular polyhedra, ellipsoids, cones, spheroids (which can be described by the lengths of their 3 principal axes), and combinations thereof or irregularly shaped. Naturally occurring nanostructures, such as gas vesicles, are frequently cylindrical with conical ends. Synthetic nanostructures may have any shape, and in one embodiment are selected from cylindrical and spherical structures.
- The shell of the hollow nanostructures is permeable to gases, and particularly to oxygen, and to mixtures comprising oxygen, such as air. Gases such as oxygen and air freely move through the hollow nanostructures of the present invention. The nanostructure shells of the present invention have oxygen permeabilities of at least about 5 barrer, in some embodiments of at least about 20 barrer. In one embodiment, the oxygen permeability of the shell is equal to or greater than the oxygen permeability of the substrate polymer. However, because the shell thickness is relatively thin (less than about 10 nm, and in some embodiments between about 1 and about 5 nm) compared to the size of the nanostructure, relatively low oxygen permeabilities of the shell materials are still useful.
- Because gases freely diffuse through the hollow nanostructures, and liquids (particularly water) do not, the shape of the nanostructures is maintained by the rigidity of the materials used to form the shell. The shell materials have a modulus of at least about 1 GPa, in some embodiments at least about 2 GPa, and in some embodiments between about 2.5 GPa and about 3.5 GPa. Shapes which are known to be stable under pressure include spheres and cylinders, cones and spheroids (which can be described by the lengths of their 3 principal axes), and combinations thereof. In one embodiment that hollow nanostructure is a sphere, and in another spheres having an average diameter of about 200 nm.
- The structures may also include reinforcing structures such as ribs, reinforcing fillers, nanofibers, structural proteins, crosslinks (ionic or covalent) combinations thereof and the like.
- The hollow nanostructures of the present invention retain their hollow structure and do not collapse during the production, sterilization and use of the articles in which they are incorporated. The maintenance or retention of the hollow nanostructure is characterized by a critical pressure of a least about 0.05 MPa and in some embodiments between about 0.1 MPa and about 0.3 MPa. and still other embodiments greater than 0.2 MPa.
- Generally the outer portion of the nanostructure is hydrophilic and the inner structure is water impermeable. This allows the nanostructure to be readily dispersed in hydrophilic substrate polymers such as hydrogels, but prevents water from seeping into the gas filled cavity. The inner and outer structures of the nanostructure shell can be formed from separate layers, such as separate layers of polymers, proteins or other shell materials, or from a single amphiphilic material having its hydrophilic portion oriented outward, and the hydrophobic portion oriented toward the interior of the hollow nanostructure or towards an inner hydrophobic layer of the shell.
- The hydrophilicity and water permeability of materials useful for forming the nanostructure may be characterized by the water permeability coefficient at 25° C. and the surface tension. Hydrophilic materials suitable for the outer structure of the shell have water permeability coefficients greater than about 100 and surface tensions greater than about 40 dyne/cm at 20° C. Water impermeable materials for the inner structure of the shell have water permeability coefficients at 25° C. of less than about 10, and surface tensions of less than about 35 dyne/cm at 20° C. In some embodiments the hydrophilic materials display contact angles of less than about 80°, and the water impermeable materials display contact angles of greater than about 100° when measured using the Wilhelmy plate method and distilled, deionized water at room temperature. Water permeability coefficients for a number of polymers are reported in Polymer Handbook, 4th Edition by J. Brandrup, Immergut, E. H., Grulke, E. A., Bloch, D.
- In one embodiment the hollow nanostructures are formed synthetically. Examples of suitable synthetic methods include physicochemical processes where the shell material is precipitated during solvent evaporation or adsorption with controlled electrostatic or chemical interactions to form the shell. On example of this method is disclosed in Nature Vol 367 Jan. 20, 1994. The hollow nanostructures may be formed by the phase separation via solvent evaporation of a polymer mixture of two or more polymers. The interfacial tensions and evaporation rates are selected such that a spherical droplet of one polymer becomes coated with a uniform layer of the other as a result of the spreading equilibria between two fluids suspended as emulsified droplets in a solvent.
- When different materials are used for the inner and outer portions of the nanostructure shell, the material from which the outer hydrophilic layer is formed may be a polymer which can be crosslinked or polymerized with itself. Examples of such materials include homo and copolymers of 2-hydroethyl methacrylate (HEMA), polyvinyl acetate, methacrylic acid, N-vinylpyrrolidone, N-vinyl acetamide, N-vinyl methyl acetamide, N,N dimethyl acrylamide, acrylic acid, glycerol monomethacrylate, MPC (2-Methacryloyloxyethyl phosphorylcholine), methyl methacrylate, hydroxyethyl acrylate, N-(1,1-dimethyl-3-oxybutyl)acrylamide, polyethylene glycol monomethacrylate, polyethylene glycol dimethacrylate, 2-ethoxyethyl methacrylate, 2-methacryloxyethyl phosphorylcholine, combinations thereof and the like. Other polymers having the water permeation coefficients and surface tensions described above may also be used. Examples include polysaccharides, hydrophilic polypeptides, polyesters, polyamides including nylons having repeating carbon sections of less than 4 carbon atoms, polyurethanes, proteoglycans, cellulose and hydrophobic backbone polymers which have hydrophilic side chains sufficient to provide the water permeation coefficients and surface tensions described above, and combinations thereof. Specific examples of polymers which may be used to form the outer shell include poly(acrylamide co-acrylic acid), poly(N-isopropylacrylamide), 2-hydroxymethacrylic ester containing polymers and copolymers, polyvinyl alcohol polymers and copolymers and the like. The polymers may have any structure, including linear, branched and brush structures. In one embodiment the outer shell is formed from a crosslinked polymer comprising at least one monomer used to form the substrate.
- Examples of materials from which an inner layer may be formed include homopolymers and copolymers comprising polyorganosiloxanes (including silicone methacrylates), fluorine containing polymers, liposomes, hydrophobic polypeptides, polyesters, polyamides, polyurethanes, polystyrenes, polyanilines, polypyrroles, combinations thereof and the like. Examples of suitable inorganic materials include oxygen permeable perovskite oxides, metalloids such as boron nitrides, metal oxides, including iron oxide, aluminum oxide, titanium dioxide, zirconium oxide, metals, such as gold, transition metal sulfides, such as ZnS and CdS, graphene, inorganic/organic hybrids such as whole shell metal oxides coated with cellulose, polytetrafluoroethane, combinations thereof and the like. Specific examples of silicone containing polymers include polydimethylsiloxane (PDMS), cross-linked poly(dimethylsiloxane), poly(silsesquioxane), poly((trimethyl silyl)propyne). Examples of fluorine containing polymers include amorphous fluoropolymers such as 2,2-bis(trifluoromethyl)-4,5-difluoro-1,3-dioxole copolymers with tetrafluoroethylene (sold under the tradename TEFLON AF), fluorinated PDMS, and fluorinated polynorbornene. Copolymers containing the foregoing and mixtures of any of the foregoing with any of the inorganic materials may also be used.
- The inner layer material may include latent reactive groups such as pentafluoromethacrylate and N-acryloxysuccinimide. Suitable latent reactive groups are disclosed in US2004/0120982 and may be added to the inner layer of the shell to allow reaction between the inner and outer layer materials. In another embodiment, the inner and outer shell materials have alternating charges, allowing the materials to associate via charge interaction. Examples of such materials include carboxylic acid metal salts, carboxylic acid/quaternary ammonium salts, sulfonic acid metal salts, sulfonic acids/quaternary ammonium salts.
- Alternatively, the shell can be formed from one or more zwitterionic material, amphiphilic material, or combination thereof. Suitable zwitterionic and micellar materials are disclosed below. The amphiphilic materials are assembled such that the hydrophobic portion is oriented in toward the cavity of the nanostructure and the hydrophilic portion is oriented out toward the substrate. The amphiphilic material is then crosslinked to provide a nanostructure having the desired size, shape and modulus.
- In another embodiment, the hollow nanostructures may be formed around a seed or template particle which is removed after at least part of the nanostructure is formed. In this embodiment, polymerization reactions, such as emulsion polymerization, microemulsion polymerization, suspension polymerization or liposome or micelle formation followed by crosslinking may be used to form the shell layer(s). Suitable template materials include polymeric microspheres, water-in-oil emulsion droplets, lyotropic phases exhibiting a multilamellar vesicular structure. The seed or template may be removed by calcination or solvent etching after the shell or at last one layer of the shell is formed. Examples of this synthetic method have been disclosed in “Graphene: A Perfect Nanoballoon”, Leenaerts et al., Applied Physics Letters, 93, 193107 (2008). Dept Physics, Univ. Antwerpen; “Growing Nanoballoons and Nanotubes of Pure polymer from a Microcapsule”, Fei et al., Inst. Textiles, Macromol. Rapid Commun 29 1882-1886, (2008). The Hong Kong Polytechnic University; “Silicone Nanocapsules Templated Inside the Membranes of Cationic Vesicles”, Kepczynski et al., Langmuir, 23 7314-7320, (2007). Jagiellonian Univ. Krakow Poland; “Encapsulation of Inorganic Particles with Nanostructured Cellulose”, Nelson and Deng, Macromol. Mater. Eng., 292 1158-1163, (2007). Georgia Tech.; “Stable Polymeric Nanoballoons: Lyphilization and Rehydration of Cross-linked Liposomes”, Liu and O'Brian, J. Am. Chemical Society, 124 6037-6042, (2002), Chemistry Dept. Univ. Arizona; “Nanoparticles and nanoballoons of amorphous boron coated with crystalline boron nitride”, Appl. Phys. Lett. 79, 188 (2001); “Carbon Nanoballoon Produced by Thermal Treatment of Arc Soot”, New diamond and Frontier Carbon Technology, 15 No 2 (2005). Toyohashi University of Technology Japan; Fabrication of Core-Shell Fe3O4/polypyrole and Hollow Polypyrole Microspheres, Polymer Composites 2009. Lu et al., Jilin University, China. These disclosures are incorporated herein by reference.
- Alternatively carbon hollow nanostructures may be formed via the thermal treatment of arc soot at more than 2400° C. Macromol. Mat. Eng. 2007 292, 1158-1163 “Encapsulation of Inorganic Particles with Nanostructured Cellulose”.
- In another embodiment, the nanostructures may be naturally occurring gas vesicles isolated from bacteria, such as from cyanobacteria (such as Anabaena and Microcystis, Ocillatoria and Calothrix), methogens and halophiles. Naturally occurring gas vesicles may be isolated by known methods such as those disclosed in WO 98/21311, which is incorporated in its entirety by reference. Isolated naturally occurring nanostructures may be used “as-isolated” or may be coated or encapsulated as disclosed herein.
- The oxygen permeable particles (both solid and hollow) may be encapsulated prior to incorporation into the reactive mixture used to make the polymer. This is particularly useful when either the core of a solid oxygen permeable particle or an inner layer of a hollow nanostructure is made from a water impermeable material or an amphiphilic material.
- As used in the present invention “encapsulated” means surrounding the oxygen permeable particles with another material or entrapping the oxygen permeable particle within another material. Suitable means of encapsulating include coating the oxygen permeable particles, entrapping the oxygen permeable compounds within another material, to form for example a liposomal, micellar or polymeric structure around the oxygen permeable particles, combinations thereof and the like. The oxygen permeable particles may be encapsulated for a number of reasons. For example, oxygen permeable particles may be coated with a polymer to prevent them from causing an immunological response when incorporated into a medical device. In one embodiment the oxygen permeable particles may be encapsulated to change the properties of the particles, such as, for example, to make them more compatible with the components of the reactive mixture used to make the polymer. In another embodiment the particles may be encapsulated to help maintain a desired particle size, to prevent or limit aggregation or to provide the final article with other desired properties, such as but not limited to refractive index, biocompatibility (including immunological response, protein or lipid uptake), combinations thereof and the like. For example, the oxygen permeable particles may be encapsulated within a hydrophilic shell and dispersed within the reactive mixture. In addition to displaying improved compatibility with a hydrophilic reaction mixture, encapsulation also prevents the formation of hydrophobic sites within a lens formed from said reaction mixture. Hydrophobic sites may cause protein denaturation and lens fouling. Other reasons for encapsulation, and benefits therefrom will be apparent to those of skill in the art.
- In one embodiment the oxygen permeable particles may be dispersed or suspended in the reactive mixture. The particles may be dispersed via ionic or steric forces, or a combination thereof. In one embodiment oxygen permeable particles form stable dispersions displaying particle sizes of less than about 1000 nm, which remain dispersed for at least about one hour, and in some embodiments at least about one day, and in some embodiments for a week or more. In one embodiment, the reaction mixture may further comprise at least one surface active agent may be added. Suitable surface active agents are compatible with the reactive mixture and suspended or dispersed particles, and do not cause haze. Suitable surface active agents include small molecule surfactants, polymeric surfactants, amphiphilic copolymers, combinations thereof and the like. Examples of suitable surface active agents include PEG-120 Methyl Glucose Dioleate (
DOE 120, commercially from Lubrizol), PVP, polyvinyl alcohol/polyvinyl acetate copolymers, amphiphilic statitistical or block copolymers such as silicone/PVP block copolymers, polyalkylmethacrylate/hydrophilic block copolymers, organoalkoxysilanes such as 3-aminopropyltriethoxysilane (APS), methyl-triethoxysilane (MTS), phenyl-trimethoxysilane (PTS), vinyl-triethoxysilane (VTS), and 3-glycidoxypropyltrimethoxysilane (GPS), silicone macromers having molecular weights greater than about 10,000 and comprising groups which increase viscosity, such as hydrogen bonding groups, such as but not limited to hydroxyl groups and urethane groups and mixtures thereof. - Where the dispersing agent is a polymer, it can have a range of molecular weights. Molecular weights from about 1000 up to several million may be used. The upper limit is bounded only by the solubility of the dispersing agent in the reactive mixture.
- When a dispersing agent is used, the dispersing agent may be present in amounts between about 0.001% to about 40 weight %, based upon the weight % of all components in the reactive mixture. In some embodiments the dispersing agent may be present in amounts between about 0.01 weight % and about 30 weight % and in other embodiments between about 0.1 weight % and about 30 weight %. In some embodiments, the dispersing agent is also a reactive component used to form the polymeric article, such as where a contact lens comprising polyvinyl alcohol is produced. In these embodiments the amount of dispersing agent used may be up to about 90 weight % and in some embodiments up to about 100 weight % based upon the weight % of all components in the reactive mixture.
- In one embodiment the oxygen permeable particles are coated with a coating composition. Suitable coating compositions may be selected to provide any of the features described above. For example, where compatibility with a conventional hydrogel reactive mixture is desired, suitable coating compositions include anionic, potentially anionic, cationic, potentially cationic, zwitterionic and polar neutral coating compositions, combinations thereof and the like. Examples of anionic and potentially anionic polymers which may be used as coating materials include, polyacrylic acid, hyaluronic acid, dextran sulfate, alginates, copolymers and mixtures thereof and the like.
- Examples of cationic and potentially cationic polymers include poly(diallyldimethylammonium chloride)(PDADMAC), chitosan, poly(quats), poly(amines), poly(pyridines), copolymers and mixtures thereof and the like.
- Examples of zwitterionic polymers include_poly(sulfobetaines), poly(carboxybetaines), poly(phosphobetaines), copolymers thereof and the like. Specific examples of zwitterionic polymers include poly(3-[N-(2-acrylamidoethyl)dimethylammonio]propanesulfonate) poly(3-[N-(2-methylacrylamidoethyl)dimethylammonio]propanesulfonate), poly(3-[N-(2-methacryloxyethyl)dimethylammonio]propanesulfonate, poly(3-(N,N-dimethyl-N-(4-vinyl-phenyl)-ammonio)propanesulfonate, poly(3-[N-(2-acrylamidoethyl)dimethylammonio]propionate), poly(3-[N-(2-methylacrylamidoethyl)dimethylammonio]propionate), poly(3-[N-(2-methacryloxyethyl)dimethylammonio]propionte, poly(3-(N,N-dimethyl-N-(4-vinyl-phenyl)-ammonio)propionate, and poly(2-methacryloyloxyethyl phosphorylcholine. In some embodiments, anionic and zwitterionic or cationic and zwitterionic coating compositions comprise the outermost layer. The oxygen permeable particles may be coated with one or more layers.
- Suitable methods for coating include 1) deposition of alternating layers of cationic/anionic polymers, polyacid/polybases, or polymeric hydrogen donor/acceptor species, 2) plasma treatment, 3) divergent and convergent graft (co)polymerization via conventional or controlled radical polymerization, 4) simple chemical modification of the surface with small molecules, such as grafting, or 5) surface degradation by chemical means, i.e. acid/base catalyzed hydrolysis, modification of the particle surface via ion, x-ray, gamma ray, or electron bombardment. Other modifications methods include oxidative plasma treatment and controlled gas plasma deposition.
- In another embodiment the oxygen permeable particles are encapsulated within a micelle. This can be accomplished by a variety of routes, including but not limited to 1) direct micellization/solubilization of PDMS fluid to form an oil-in-water emulsion or micro-emulsion with a suitable surfactant system, 2) formation of an emulsion/micro-emulsion and subsequent curing of a reactive silicone, where the reactive silicone could consist of, but is not limited to a silanol functional polydialkyl siloxane oligomer, 3) formation of an emulsion or micro-emulsion and subsequent metal-catalyzed curing of reactive silicones, where the reactive silicone could consist of, but is not limited to a mixture of a vinyl- or allyl-functional polydialkyl siloxane oligomer and a hydride functional polydialkyl siloxane oligomer, and 4) preparation of siloxy-containing latexes via emulsion or micro-emulsion free radical polymerization using vinyl siloxy macromers such as, but not limited to polydialkyl siloxanes, such as mPDMS (monomethacryloxypropyl terminated mono-n-butyl terminated polydimethylsiloxane) or OHmPDMS (mono-(3-methacryloxy-2-hydroxypropyloxy)propyl terminated, mono-butyl terminated polydimethylsiloxane)), SiMAA DM (Methyl-bis(trimethylsilyloxy)-silyl-propylglycerol-dimethacrylate), or combinations thereof. The above-mentioned siloxy-emulsions/micro-emulsions may also be prepared directly in a reactive monomer mixture with appropriate monomer and diluent selection. Particles formed via the above-mentioned emulsion/micro-emulsion processes can be further stabilized by incorporation of a cross-linking agent during the curing process. Selection of cross-linking agents depends on the functionality of the reactive-silicone employed in particle formation. Examples of silicone cross-linking agents are well known to those skilled in the art and include, but are not limited to SiMAA DM (Methyl-bis(trimethylsilyloxy)-silyl-propylglycerol-dimethacrylate), tetra-alkoxy silanes and poly-functional vinyl, allyl, or silyl-hydride moieties with appropriate hydrosilylating metal catalysts.
- Siloxy-emulsions/micro-emulsions may be formed from a variety of surfactant systems, including both ionic and non-ionic detergents. Surfactants that are commonly used in the preparation of latexes may be employed and are obvious to those skilled in the art. Examples of said surfactants include, but are not limited to alkyl sulfates, alkyl sulfonates, alkylbenzene sulfonates, fatty acids, alkyl ethoxylates, alkyl quaternary ammonium salts, alkyl glucocides, polysorbates, and all combinations thereof.
- Reactive surfactants may also be employed in the preparation of silicone microemulsion systems. Also known in the literature as “surfiners,” these surface-active compounds contain a reactive group at the hydrophobic or hydrophilic terminus and are capable of taking part in the polymerization process, thereby incorporating themselves into final polymeric particle and eliminating or minimizing the need for surfactant removal. Examples of such materials that may be used to form silicone microemulsion particles include but are not limited to allyl polyalkylene glycol ethers, vinyl polyalkylene glycol ethers, allyl polyalkylene glycol ether sulfates, methacrylic acid esters of alkyl polyethylene glycol ethers, and vinyl polyethylene glycol ethers. These agents may be used as a substitute for or in combination with the above-mentioned standard emulsion polymerization surfactants.
- In addition to lower molecular weight surfactants, polymeric surfactants and emulsifying agents may also be used in the preparation of siloxy-emulsions/micro-emulsions. Examples of such polymeric surfactants are well-known to those skilled in the art and include, but are not limited to pluronic/polaxamer surfactants, (co)polymers of N-vinyl pyrrolidone, copolymers of various hydrophobic monomers with vinyl alcohol, poly(ethylene-co-maleic anhydride) and combinations there of.
- Embodiments involving the preparation of siloxy-latexes via free radical micro-emulsion polymerization, using vinyl siloxy macromers, such as, but not limited to SiMAA2 DM, OHmPDMS, and/or mPDMS, or combinations thereof, allow for the facile synthesis of high Dk particles with tunable compositions, and consequently, controlled structures and properties. Generally, this embodiment involves a micro-emulsion composed of one or a combination of the above-mentioned surfactants in water, at least one siloxy macromer, a cross-linking reactive monomer (such as SiMAA2 DM, EGDMA (ethylene glycol dimethacrylate) or DVB (divinylbenzene)), and a water-soluble free radical initiator. Depending on choice of initiator, the polymerization may be initiated via thermal, photochemical, or redox pathways. In a more preferred embodiment, the ratio of OHmPDMS to SiMAA2 DM may be varied to obtain final particles with tailored physical properties, including but not limited to desirable refractive index values and increased particle stability.
- In the above embodiment, “water-soluble free radical initiator” is defined as any compound that, under specific conditions (i.e. temperature, light intensity and wavelength), generates one or multiple active radical species. These compounds are well known to those skilled in the art. Examples of water-soluble free radical initiators that may be employed within this embodiment include but are not limited to VA-044 (2,2′-Azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride), V-50 (2,2′-Azobis(2-methylpropionamidine)dihydrochloride), VA-057 (2,2′-Azobis[N-(2-carboxyethyl)-2-methylpropionamidine]hydrate, VA-060 (2,2′-Azobis {2-[1-(2-hydroxyethyl)-2-imidazolin-2-yl]propane}dihydrochloride), VA-061 (2,2′-Azobis[2-(2-imidazolin-2-yl)propane]), VA-067 (2,2′-Azobis(1-imino-1-pyrrolidino-2-ethylpropane)dihydrochloride), VA-80 (2,2′-Azobis {2-methyl-N-[1,1-bis(hydroxymethyl)-2-hydroxyethyl]propionamide}), VA-086 (2,2′-Azobis[2-methyl-N-(2-hydroxyethyl)propionamide], VPE-0201 (poly(ethylene glycol) macro initiator MW=2000 g/mole), VPE-0401 (poly(ethylene glycol) macro initiator MW=4000 g/mole), VPE-0602 (poly(ethylene glycol) macro initiator MW=6000 g/mole), potassium persulfate, and any water-soluble photo-initiator. The invention is not restricted to the use of water-soluble free radical initiators. Micro-emulsion systems may be prepared with conventional oil soluble initiators.
- In an additional preferred embodiment, the choice of water-soluble free radical initiator may dictate the final properties of the particles generated by emulsion/micro-emulsion polymerization. For example, if a hydroxyl- or PEG-functional initiator is employed in the polymerization, the surface properties of the final siloxy-latex may be modified, leading to controlled surface features, such as but not limited to, increased surface polarity, hydrophilicity, and consequently, biocompatibility.
- Once formed, the oxygen permeable polymeric particles may covalently bond to, may associate with, or may be physically entrapped within their stabilizing surfactants. The particles may have a core/shell structure, containing the high Dk material in the core and the stabilizing surfactants and other stabilizing moieties in the shell. Once formed the micelle may covalently bond to the hydrogel polymer, may associate with the hydrogel polymer, or may be physically entrapped within the hydrogel polymer. The micelle may have a core/shell structure. Suitable compositions for forming micellar coatings may be selected to provide any of the features described above. For example, where compatibility with a conventional hydrogel reactive mixture is desired, suitable micelle compositions include that yield in the final particle, an anionic, cationic, zwitterionic, or polar-neutral micelle surface. Such moieties on the surface of micelle particles can be introduced by employing a silicone-reactive capping agent or surfactant during the emulsion/micro-emulsion process.
- Any of the anionic, cationic or zwitterionic polymers disclosed above as coating compounds may be used in forming micellar coatings, so long as one end comprises the cationic, zwitterionic or anionic groups disclosed above, and the other end is compatible with said oxygen permeable particle. Examples of moieties which may be included at the hydrophobic terminus include alkoxy silanes, polychloro-silanes, vinyl silanes, polyfunctional allyl moieties, and polsilyl-hydrides, etc.), an aliphatic linker (typically propyl or butyl), and the like. Monomers and oligomers may also be used to form the micellar coatings of the present invention. Specific examples include alkyl benzene sulfonate and alkyl ethoxylate made by the methods described in IN 2003KO00640 by Wacker Metroark Chemicals Ltd. Other patents involving silicone ME polymerizations include U.S. Pat. No. 5,661,215, and U.S. Pat. No. 6,316,541.
- Suitable methods for forming a micellar coating include those that yield in the final particle, an anionic, cationic, zwitterionic, or polar-neutral surface. Such moieties on the surface of micelle particles can be introduced by employing a silicone-reactive capping agent or surfactant during the emulsion process. The capping agents are also surface-active and include a hydrophobic silicone-reactive moiety at one terminus (including, but not limited to alkoxy silanes, polychloro-silanes, vinyl silanes, polyfunctional allyl moieties, and polsilyl-hydrides, etc.), an aliphatic linker (typically propyl or butyl), and the desired polar or ionic group at the other terminus. The surface chemistry of the micelle particles can be easily manipulated by appropriate selection of capping agent in combinations thereof and the like.
- Generally an emulsion is formed by mixing the selected surfactant in a suitable solvent above the critical micelle concentration, and preferably in concentrations greater than about 10 weight % and in some embodiments between about 15 and about 25 weight % surfactant, and in some embodiments between about 15 to about 20 weight %. Both emulsions and microemulsions can be used in the present invention, and wherever emulsions are disclosed, microemulsions may also be formed depending upon the particles and surfactants selected. The emulsion is heated and the oxygen permeable particles added. In some embodiments crosslinking agents may be added to form crosslinked micelles.
- In another embodiment the oxygen permeable particles are encapsulated into liposomes. Suitable compositions may be selected to provide any of the features described above. For example, where compatibility with a conventional hydrogel reactive mixture is desired, phospholipids and other liposome-forming compounds may be employed. Suitable liposome forming compounds may include, but are not limited to DSPC (distearoylphosphatidylcholine), HSPC (hydrogentated soy phosphatidylcholine), and poly(ethylene glycol) conjugates with cholesterol, lipids, and phospholipids, combinations thereof, and the like.
- Suitable methods for forming liposomes include known methods, such as but not limited to mixing the desired components, sonication, membrane extrusion and the like.
- Examples of encapsulated solid oxygen permeable particles include cross-linked poly(dimethylsiloxane) core and a poly(silsesquioxane) shell prepared by Shin Etsu, Inc. (Japan) sold as X-52-7030, and having an average size distribution of 800 nm with a range from 0.2-2000 nm, dimethicone/vinyl dimethicone crosspolymer with silica treated coating, sold by Dow Corning as 9701 Cosmetic Powder.
- The oxygen permeable particles may be incorporated into the hydrogel polymers of the present invention in an oxygen permeable enhancing effective amount. As used herein, an “oxygen permeable enhancing effective amount” is an amount effective to increase the oxygen permeability of the polymer by at least about 10%, at least about 25%, and in some embodiments at least about 50%, and in other embodiments, greater than 100%, compared to the oxygen permeability of the hydrogel polymer having no oxygen permeable particles. In some embodiments the compositions of the present invention comprise oxygen permeabilities of at least 25 barrer, at least about 40 barrers, in some embodiments at least about 60 barrers, and in other embodiments at least about 80 barrers and in other embodiments at least about 100 barrers.
- The amount of oxygen permeable particles to be added to a reactive mixture can be readily determined by the desired oxygen permeability for the composition and the oxygen permeability for the polymer without any oxygen permeable particles. This may be readily done by making films of the polymers having different concentrations of the oxygen permeable particles, measuring the Dk of the films and interpolating to the desired oxygen permeability target to a concentration for the oxygen permeable particles of 100%. Additionally, for hollow nanostructures, the amount of nanostructures to be added to a reactive mixture can be readily determined by the target oxygen permeability of the system utilizing known permeability theory as described in Journal of Biotechnology 77 (2000) 151-156 “Evaluation of oxygen permeability of gas vesicles from cyanobacterium Anabaena flos-aquae”.
- The oxygen permeability of the encapsulated oxygen permeable particles will be dependent upon the properties of both the oxygen permeable particle and the encapsulating material, including, but not limited to particle size, surface area of the encapsulated particle, surface composition, thickness of the encapsulating material, degree of cross-linking in the core and shell.
- For example, in one embodiment, where the hydrogel polymer is a copolymer hydroxyethyl methacrylate (HEMA) and about 2 weight % methacrylic acid (MAA), (which has an oxygen permeability of about 20 barrers), and the particles of PDMS (which has an oxygen permeability of about 600 barrers) are used as the oxygen permeable particle, the oxygen permeable particles may be added in amounts of at least about 15 weight %, and in some embodiments between about 20 and about 70 weight %.
- The oxygen permeable particles may be added in amounts which are insufficient to undesirably impact other properties of the resulting composition. For example, where the composition will be used to make articles which must be clear to be useful, such as contact lenses, the polymer should be free from visible haze at the desired thickness of the article. In these embodiments, the polymer displays a % haze of less about 15%, in some embodiments less about 10%, and in others less than about 5% using the method described below. In another embodiment, the article is a contact lens, and the oxygen permeable particles are primarily incorporated outside the optic zone. This allows loadings of particles which have particles, particle concentrations or both which cause haze in the resulting lens.
- It is a benefit of the present invention that the oxygen permeable particles may be added to the reactive mixtures used to make conventional hydrogels. Conventional hydrogels are well known and include homo and copolymers of polyHEMA and polyvinyl alcohol. Suitable comonomers include methacrylic acid, N-vinylpyrrolidone, N-vinyl acetamide, N-vinyl methyl acetamide, N,N dimethyl acrylamide, acrylic acid, glycerol monomethacrylate, MPC (2-Methacryloyloxyethyl phosphorylcholine)), methyl methacrylate, hydroxyethyl acrylate, N-(1,1-dimethyl-3-oxybutyl)acrylamide, polyethylene glycol monomethacrylate, polyethylene glycol dimethacrylate, 2-ethoxyethyl methacrylate, 2-methacryloxyethyl phosphorylcholine combinations thereof and the like. Homo and copolymers of polyHEMA include etafilcon, polymacon, vifilcon, bufilcon, crofilcon, genfilcon, hioxifilcon, lenefilcon, methafilcon, ocufilcon, perfilcon, surfilcon, tetrafilcon. Homo and copolymers of polyvinyl alcohol may also be used, including atlafilcon, and nelfilcon. Homo and copolymers of methyl methacrylate and hydrophilic monomers such as N,N-dimethyl methacrylamide or N-vinyl pyrrolidone, such as lidofilcon, may also be used. However, the oxygen permeable particles may be used to increase the oxygen permeability of any hydrogel formulation, including silicone hydrogels such as but not limited to balafilcon, lotrafilcon, aquafilcon, senofilcon, galyfilcon, narafilcon, comfilcon, oxyfilcon, siloxyfilcon and the like. When a USAN name is listed it includes all variations under the same name. For examples, lotrafilcon includes both lotrafilcon A and B.
- The oxygen permeable particles of the present invention may be added directly to the reaction mixture used to form the hydrogel polymer or may be soaked or imbibed into the hydrogel polymer post cure.
- The reactive components and oxygen permeable particles are mixed together to form the reactive mixture. The reactive mixture may optionally include diluents to help with processing or provide improved compatibility. Suitable diluents are known in art and may be selected based upon the polymer which is selected. For example, suitable diluents for conventional hydrogels include organic solvents, water or mixtures hereof. In one embodiment when a conventional hydrogel is selected as the polymer, organic solvents such as alcohols, diols, triols, polyols and polyalkylene glycols may be used. Examples include but are not limited to glycerin, diols such as ethylene glycol or diethylene glycol; boris acid esters of polyols such as those described in U.S. Pat. Nos. 4,680,336; 4,889,664 and 5,039,459; polyvinylpyrrolidone; ethoxylated alkyl glucoside; ethoxylated bisphenol A; polyethylene glycol; mixtures of propoxylated and ethoxylated alkyl glucoside; single phase mixture of ethoxylated or propoxylated alkyl glucoside and C2-12 dihydric alcohol; adducts of ε-caprolactone and C2-6 alkanediols and triols; ethoxylated C3-6 alkanetriol; and mixtures of these as described in U.S. Pat. Nos. 5,457,140; 5,490,059, 5,490,960; 5,498,379; 5,594,043; 5,684,058; 5,736,409; 5,910,519. Diluents can also be selected from the group having a combination of a defined viscosity and Hanson cohesion parameter as described in U.S. Pat. No. 4,680,336.
- It may also be desirable to include one or more cross-linking agents, also referred to as cross-linking monomers, in the reaction mixture, such as ethylene glycol dimethacrylate (“EGDMA”), trimethylolpropane trimethacrylate (“TMPTMA”), glycerol trimethacrylate, polyethylene glycol dimethacrylate (wherein the polyethylene glycol preferably has a molecular weight up to, e.g., about 5000), and other polyacrylate and polymethacrylate esters, such as the end-capped polyoxyethylene polyols described above containing two or more terminal methacrylate moieties. The cross-linking agents are used in the usual amounts, e.g., up to about 2 weight % of reactive components in the reaction mixture. Alternatively, if any of the monomer components act as a cross-linking agent, the addition of a separate crosslinking agent to the reaction mixture is optional. Examples of hydrophilic monomers that can act as the crosslinking agent and when present do not require the addition of an additional crosslinking agent to the reaction mixture include polyoxyethylene polyols containing two or more terminal methacrylate moieties.
- The reactive mixture may contain additional components such as, but not limited to, UV absorbers, medicinal agents, antimicrobial compounds, reactive tints, pigments, copolymerizable and nonpolymerizable dyes, release agents and combinations thereof.
- A polymerization initiator may also be included in the reaction mixture. Polymerization initiators include compounds such as lauryl peroxide, benzoyl peroxide, isopropyl percarbonate, azobisisobutyronitrile, and the like, that generate free radicals at moderately elevated temperatures, and photoinitiator systems such as aromatic alpha-hydroxy ketones, alkoxyoxybenzoins, acetophenones, acylphosphine oxides, bisacylphosphine oxides, and a tertiary amine plus a diketone, mixtures thereof and the like. Illustrative examples of photoinitiators are 1-hydroxycyclohexyl phenyl ketone, 2-hydroxy-2-methyl-1-phenyl-propan-1-one, bis(2,6-dimethoxybenzoyl)-2,4-4-trimethylpentyl phosphine oxide (DMBAPO), bis(2,4,6-trimethylbenzoyl)-phenyl phosphineoxide (Irgacure 819), 2,4,6-trimethylbenzyldiphenyl phosphine oxide and 2,4,6-trimethylbenzoyl diphenylphosphine oxide, benzoin methyl ester and a combination of camphorquinone and ethyl 4-(N,N-dimethylamino)benzoate. Commercially available visible light initiator systems include Irgacure 819, Irgacure 1700, Irgacure 1800, Irgacure 819, Irgacure 1850 (all from Ciba Specialty Chemicals) and Lucirin TPO initiator (available from BASF). Commercially available UV photoinitiators include Darocur 1173 and Darocur 2959 (Ciba Specialty Chemicals). These and other photoinitiators which may be used are disclosed in Volume III, Photoinitiators for Free Radical Cationic & Anionic Photopolymerization, 2nd Edition by J. V. Crivello & K. Dietliker; edited by G. Bradley; John Wiley and Sons; New York; 1998, which is incorporated herein by reference. The initiator is used in the reaction mixture in effective amounts to initiate photopolymerization of the reaction mixture, e.g., from about 0.1 to about 2 parts by weight per 100 parts of reactive monomer. Polymerization of the reaction mixture can be initiated using the appropriate choice of heat or visible or ultraviolet light or other means depending on the polymerization initiator used. Alternatively, initiation can be conducted without a photoinitiator using, for example, e-beam. However, in one embodiment when a photoinitiator is used, preferred initiators induce bisacylphosphine oxides, such as bis(2,4,6-trimethylbenzoyl)-phenyl phosphine oxide (Irgacure 819®) or a combination of 1-hydroxycyclohexyl phenyl ketone and bis(2,6-dimethoxybenzoyl)-2,4-4-trimethylpentyl phosphine oxide (DMBAPO), and a preferred method of polymerization initiation is visible light. A preferred is bis(2,4,6-trimethylbenzoyl)-phenyl phosphine oxide (Irgacure 819®).
- Articles, such as biomedical devices, and in some embodiments ophthalmic devices, may be prepared by mixing reactive components and the diluent(s), if used, with a polymerization initiator and curing by appropriate conditions to form a product that can be subsequently formed into the appropriate shape by lathing, cutting and the like. Alternatively, the reaction mixture may be placed in a mold having the shape of the desired article and subsequently cured into the desired article.
- For example, where the reactive mixture is used to form a contact lens, any of the known processes for curing the reaction mixture in the production of contact lenses, including spincasting and static casting, may be used. Spincasting methods are disclosed in U.S. Pat. Nos. 3,408,429 and 3,660,545, and static casting methods are disclosed in U.S. Pat. Nos. 4,113,224 and 4,197,266. In one embodiment, the method for producing contact lenses comprising the polymer of this invention is by the direct molding of the reaction mixture, which is economical, and enables precise control over the final shape of the hydrated lens. For this method, the reaction mixture is placed in a mold having the shape of the final desired lens, and the reaction mixture is subjected to conditions whereby the reactive components polymerize, to thereby produce a polymer/diluent mixture in the shape of the final desired lens.
- The compositions of the present invention have a balance of properties which makes them particularly useful. In one embodiment, where the compositions are used to make lenses, and particularly contact lenses, such properties include clarity, water content, oxygen permeability and contact angle. Thus, in one embodiment, the biomedical devices are contact lenses having a water content of greater than about 20%, and in some embodiments greater than about 30%.
- As used herein clarity means substantially free from visible haze. Clear lenses have a haze value of less than about 150%, more preferably less than about 100% compared to a CSI lens.
- The use of conventional hydrogels as the polymer provides additional benefits to resulting articles such as contact lenses, including contact angles below about 100°, and modulus below about 100 psi.
- In some embodiments, contact lenses formed from the compositions of the present invention have average contact angles (advancing) which are less than about 80°, less than about 75° and in some embodiments less than about 70°. In some embodiments the articles of the present invention have combinations of the above described oxygen permeability, water content and contact angle. All combinations of the above ranges are deemed to be within the present invention.
- As used herein clarity means substantially free from visible haze. Clarity may be measured via % haze which is calculated from transmittance. Transmittance may be measured via ASTM D1003 using an integrating sphere hazemeter. The test is conducted by taking four different consecutive readings and measuring the photocell output as follows
- T1=specimen and light trap out of position, reflectance standard in position
T2=specimen and reflectance standard in position, light trap out of position
T3=light trap in position, specimen and reflectance standard out of position
T4=specimen and light trap in position, reflectance standard out of position
The quantities represented in each reading are incident light, total light transmitted by specimen, light scattered by instrument, and light scattered by instrument and specimen, respectively. - Total transmittance Tt and diffuse transmittance Td are calculated as follows
-
T t =T 2 /T 1 -
T d =[T 4 −T 3(T 2 /T 1)]/T 1 - The percentage of haze is calculated as follows
-
Haze percent=T d /T t×100 - The water content of contact lenses was measured as follows: Three sets of three lenses are allowed to sit in packing solution for 24 hours. Each lens is blotted with damp wipes and weighed. The lenses are dried at 60° C. for four hours at a pressure of 0.4 inches Hg or less. The dried lenses are weighed. The water content is calculated as follows:
-
- The average and standard deviation of the water content are calculated for the samples and are reported.
- Modulus is measured by using the crosshead of a constant rate of movement type tensile testing machine equipped with a load cell that is lowered to the initial gauge height. A suitable testing machine includes an Instron model 1122. A dog-bone shaped sample from −1.00 lenses having a 0.522 inch length, 0.276 inch “ear” width and 0.213 inch “neck” width is loaded into the grips and elongated at a constant rate of strain of 2 in/min. until it breaks. The initial gauge length of the sample (Lo) and sample length at break (Lf) are measured. Twelve specimens of each composition are measured and the average is reported. Percent elongation is =[(Lf −Lo)/Lo]×100. Tensile modulus is measured at the initial linear portion of the stress/strain curve.
- The advancing contact angle was measured using −1.00 power lenses as follows. Four samples from each set were prepared by cutting out a center strip from the lens approximately 5 mm in width and equilibrated in packing solution. The wetting force between the lens surface and borate buffered saline is measured at 23° C. using a Wilhelmy microbalance while the sample is being immersed into or pulled out of the saline. The following equation is used
-
F=2γp cos θ or θ=cos−1(F/2γp) - where F is the wetting force, γ is the surface tension of the probe liquid, p is the perimeter of the sample at the meniscus and θ is the contact angle. The advancing contact angle is obtained from the portion of the wetting experiment where the sample is being immersed into the packing solution. Each sample was cycled four times and the results were averaged to obtain the advancing contact angles for the lens.
- The Dk is measured as follows. Lenses are positioned on a polarographic oxygen sensor consisting of a 4 mm diameter gold cathode and a silver ring anode then covered on the upper side with a mesh support. The lens is exposed to an atmosphere of humidified 2.1% O2. The oxygen that diffuses through the lens is measured by the sensor. Lenses are either stacked on top of each other to increase the thickness or a thicker lens is used. The L/Dk of 4 samples with significantly different thickness values are measured and plotted against the thickness. The inverse of the regressed slope is the Dk of the sample. The reference values are those measured on commercially available contact lenses using this method. Balafilcon A lenses (−1.00) available from Bausch & Lomb give a measurement of approx. 79 barrer. Etafilcon lenses give a measurement of 20 to 25 barrer. (1 barrer=10−10 (cm3 of gas×cm2)/(cm3 of polymer×sec×cm Hg)).
- Si content was measured via neutron activation. All samples, standards, and quality controls are irradiated for 15 seconds, allowed to decay for 120 seconds and counted for 300 seconds. The concentration of silicon is determined by measuring the 1779 keV gamma-ray from the decay of 28Al (t1/2=2.24 minutes). The 28Al is produced via the (n,p) reaction on 28Si. Three geometrically equivalent silicon standards are analyzed with the sample set. The standards are prepared by spiking paper pulp with silicon from a 10.00±0.05 mg/mL certified solution standard (High Purity Standards). The results are blank corrected for the 28Al signal from the blank high-density polyethylene sample irradiation vial. NIST SRM 1066a Octaphenylcyclotetrasiloxane is co-analyzed with the samples as a quality control check for the analysis. The certified silicon concentration in this SRM is 14.14±0.07 Wt. % Si. The average value for the analysis of three 10 mg aliquots of the SRM was 14.63±0.70 Wt. % Si.
- Surface roughness was measured via AFM using a Digital Instruments Nanoscope, a scan size of 20 μm and a scan rate of 7.181 Hz. For each sample 256 scans were processed and the data scale employed was 1000 μm. The engage X and Y positions were −19783.4 and −42151.3 μm, respectively.
- SEM Surface characterization: Surface images were captured from all samples on both the concave and convex surfaces at three locations (left, middle and right). The imaging was performed using an FEI Quanta Environmental SEM using an accelerating voltage of 25 kV and 5 nA of beam current at 5000× magnification for all locations in SE and BSE imaging modes.
- SEM Profile Characterization: Profile (cross-section) images were captured using the same beam conditions as the surface images. Since the entire cross section of the lens could not be imaged at 5 k× magnification creating mosaics of the images was necessary to view the entire cross-section of each lens. Images were captured in serial at 5 k× magnification starting near the concave side of the lens (top), then stepped frame by frame through the lens until the convex edge of the lens was eventually imaged. The individual images were then merged together using Photoshop.
- The Examples below further describe this invention, but do not limit the invention. They are meant only to suggest a method of practicing the invention. Those knowledgeable in the field of contact lenses as well as other specialties may find other methods of practicing the invention. However, those methods are deemed to be within the scope of this invention.
- Some of the materials employed in the Examples are identified as follows:
- BAGE: Boric acid glycerol ester
DBS: N-Dodecylbenzenesulfonic acid, from Sigma Aldrich
HEMA: 2-hydroxyethyl methacrylate (99% purity)
MAA: methacrylic acid (99% purity)
OHmPDMS: mono-(3-methacryloxy-2-hydroxypropyloxy)propyl terminated, mono-butyl terminated polydimethylsiloxane), (612 molecular weight), DSM Polymer Technology Group
SiMAA DM: Methyl-bis(trimethylsilyloxy)-silyl-propylglycerol-dimethacrylate, DSM Polymer Technology Group, made according to Example Preparation in US2005/0255231
Si microparticle: a cross-linked poly(dimethylsiloxane) core and a poly(silsesquioxane) shell (Shin Etsu, Inc. (Japan), X-52-7030, with an average size distribution of 800 nm with a range from 0.2-2000 nm, as determined by the manufacturer via SEM). - Monomer mix comprising 94.90% HEMA, 1.94% MAA, 0.95% Norbloc, 1.33% Irgacure 1700, 0.77% EGDMA, 0.09% TMPTMA, and 0.02% Blue HEMA (w/w) in BAGE diluent (52:48 monomer:diluent) herein referred to as reactive monomer mix (RMM) was prepared and used for Examples 1-11.
- In the preparation of examples 1-10 the desired mass of Si microparticles was added to an amber scintillation vial followed by addition of etafilcon RMM (10 g). The scintillation vial was capped and rolled for 2 hours prior to being degassed in vacuo (10 minutes) and used to prepare lenses. Levels of microparticles and RMM employed for each formulation are listed in Table 1, below. Lenses were then prepared for each example by dosing each Si microparticl monomer mix into separate front curves via pipette.
- Example 11 in Table 1 was prepared by suspending half of the mass of the microparticles required in 2.4 g ethylene glycol and the other half in 5.2 g of monomer mix without BAGE. The mixture was then further diluted with BAGE and homogenized via high-shear mechanical mixing. The resulting monomer mix was degassed for 10 minutes in vacuo. The high viscosity of Example 11 required that it be dosed into the front-curves via a pressurized syringe.
- All lenses were prepared at −1.0 power using Zeonor (Zeon Chemical) front/back curves. Curing was carried-out in an N2-purged glove box at 50° C. for 10 minutes under a TL03 lamp (400 nm) at an intensity of 3.4 mW/cm2. Lenses were demolded and released in a deionized water-bath at 90° C. prior to being stored in Borate Buffered Saline Solution in individual crimp-sealed, glass vials. All lenses were sterilized at 121° C. for 30 minutes in an autoclave prior to analysis.
-
TABLE 1 Si MP Diluent Reactive % Si MPtheo % SiTheo in Ex# mass (g) mass(g) monomer(g) in Lens Lens 1 0.000 4.8 5.2 0.0 0.0 2 0.125 4.8 5.2 2.4 0.9 3 0.250 4.8 5.2 4.6 1.7 4 0.500 4.8 5.2 8.8 3.3 5 0.750 4.8 5.2 12.6 4.8 6 1.000 4.8 5.2 16.1 6.1 7 1.250 4.8 5.2 19.4 7.4 8 1.500 4.8 5.2 22.4 8.5 9 1.750 4.8 5.2 25.2 9.6 10 2.800 4.8 5.2 35.0 13.3 11 15.600 0.0 5.2 75.0 28.5 - The Dk, water-content, and Si content were measured for each set of lenses.
- The results for each mixture are listed in Table 2 below. It is readily apparent from the data that as the level of silicone microparticles is increased from 0% to 64.3%, the resulting lens Dk increases from 20 to 76 units.
FIG. 1 is a graph of Dk versus silicone microparticle concentration in the final lens.FIG. 1 , shows a positive, non-linear polynomial trend. - When Dk is plotted against the level of elemental Si in the lens (as in
FIG. 2 ), a similar non-linear polynomial is obtained. For comparative purposes two separate data points have been inserted intoFIG. 2 to represent current SiH benchmarks, Oasys (% Si=15.0, Dk=104) and Advance (% Si=13.0, Dk=60). By comparing these benchmarks to the data obtained in Examples 1-11, the addition of silicone microparticles does increase the Dk of the resulting polymers. -
TABLE 2 % Si NP % SiTheo of % SiObs % Water Ex# in Lens Lens of Lens Content Dk Units 1 0.0 0.0 0 60.5 20 2 2.35 0.9 1 60.0 20 3 4.59 1.7 2 58.7 ND 4 8.77 3.3 3 58.5 22 5 12.61 4.8 5 58.2 23 6 16.13 6.1 6 57.6 23 7 19.38 7.4 7 57.5 25 8 22.39 8.5 9 58.5 29 9 25.18 9.6 9 56.9 31 10 35.00 13.3 13 57.3 34 11 64.3 28.5 24 55.7 76 - An SEM micrograph of the lens of Example 10 is shown at
FIG. 3 . All locations imaged by SEM had very rough surfaces containing many clusters of particles. Generally the topography and particle clustering was homogenous throughout the sample (on both sides of the lenses). Individual particle sizes were not able to be measured due to the clustering of the particles. Through observation of SEM images the particles were estimated to be between about 600 and about 1000 nm in size. - The SEM cross-sections of the lenses looked nearly homogenous to that of the surface images, consisting of clustered particles resulting in a rough topography.
- Water-soluble initiator, VA-044, was purchased from Wako Specialty Chemical Company and was also used as received.
- Each of the particle dispersions, having the compositions listed in Table 3, were made as follows. Water and DBS were added to a 1 L, 3-necked, jacketed reaction flask, equipped with a mechanical stirrer and thermal probe. The water and DBS were heated to 44° C. and stirred under a nitrogen blanket until a transparent microemulsion was formed. After 30 minutes of stirring at 300 rpm under nitrogen, an aqueous VA-044 solution (200 mg in 1 mL DI water) was added by syringe and allowed to mix. Both OHmPDMS and SiMAA DM were blended together and the resulting mixture was added drop-wise to the microemulsion while stirring at 300 rpm. After all of the silicone mixture was added (about 3-4 hours), the addition funnel was removed and the flask was sealed with a vented rubber septum. The reaction was kept under a nitrogen atmosphere at 44° C. overnight. The following morning, an additional 200 mg VA-044 in 1 mL DI water was added to the microemulsion. The microemulsion was then allowed to react for an additional four hours.
- Each dispersion listed in Table 3 was characterized via dynamic light scattering (DLS) with a Malvern-ZetaSizer Nano-S detector. After each reaction was complete, an aliquot was removed and diluted 10-fold. The diluted dispersion was then analyzed by DLS to obtain the z-average particle size distribution. Measurements were also taken after dialysis of each dispersion. Data files from the DLS were processes using CUMULANTS analysis function included in the detector software. All data files generated good fits within the CUMULANTS curve. The hydrodynamic diameters of each resulting Silicone ME are listed in Table 4 below with their corresponding PDI widths and % PDI values.
-
TABLE 3 OHmPDMS H2O DBS Ex. # (g) SiMAA DM (g) (g) (g) VA-044 (mg) 12 24 96 350 80 400 13 48 72 350 80 400 14 72 48 350 80 400 15 96 24 350 80 400 -
TABLE 4 Ex. # Z-Avg. DH (nm) PDI Width (nm) % PDI 12 46.7 (0.2) 16.2 34.7 13 34.8 (0.2) 10.3 29.6 14 44.2 (0.2) 15.7 35.5 15 65.1 (0.2) 35.5 54.6 - The dispersions are stable in water for at least 2 months. Any settling is readily redispersed with mild agitation.
- Dispersions having 50:50 HO-mPDMS and SiMAA DM in water were made as above. This dispersion was dialyzed against DI water using a 3500 MWCO regenerated cellulose dialysis membrane from Spectrapore. The resulting dispersion was stable for over 2 months.
- Frequency histograms of the Examples 12-15 are attached. The data files generated from DLS of Examples 12-15 correlated well using CUMULANTS fit, indicating Gaussian distribution of particle size and evidencing low or no aggregation in the dispersions. This is shown graphically by the histograms shown in
FIGS. 4-7 .
Claims (55)
1. A composition comprising a hydrogel polymer having distributed therein an oxygen enhancing effective amount of oxygen permeable particles having an oxygen permeability of at least about 100 barrer and average particle size less than about 5000 nm.
2. The composition of claim 1 wherein said composition has an oxygen permeability of at least about 40 barrer.
3. The composition of claim 1 wherein said composition has an oxygen permeability of at least about 60 barrer.
4. The composition of claim 1 wherein said composition has an oxygen permeability of at least about 100 barrer.
5. The composition of claim 1 , wherein the oxygen permeable particles are non-reactive.
6. The composition of claim 1 wherein said oxygen permeable particles have an oxygen permeability of about 100 barrer to about 6000 barrer.
7. The composition of claim 1 wherein said oxygen permeable particles have an oxygen permeability of about 300 barrer to about 1000 barrer.
8. The composition of claim 1 wherein said oxygen permeable particles have an average particle size of less than about 800 nm.
9. The composition of claim 1 wherein said oxygen permeable particles have an average particle size of less than about 600 nm.
10. The composition of claim 1 wherein said oxygen permeable particles have an average particle size of less than about 200 nm.
11. The composition of claim 1 , wherein the oxygen permeable particles are encapsulated.
12. The composition of claim 11 , wherein the oxygen permeable materials are encapsulated with materials selected from a coating, micelle, liposome, combinations thereof and the like.
13. The composition of claim 12 wherein said oxygen permeable material is encapsulated with a coating composition comprising hydroxyl groups.
14. The composition of claim 12 wherein said oxygen permeable material is encapsulated with a coating composition selected from crosslinked or uncrosslinked core/shell type micelles.
15. The composition of claim 1 wherein said wherein said oxygen permeable particles have an average particle size of less than about 100 nm.
16. The composition of claim 12 wherein said encapsulating material is compatible with said hydrogel polymer.
17. The composition of claim 1 wherein said hydrogel polymer has less than 100% haze and comprises a refractive index from 1.37 to about 1.45, and said oxygen permeable material has a refractive index within 10% of the hydrogel polymer refractive index.
18. The composition of claim 1 wherein said hydrogel polymer has less than 100% haze and said oxygen permeable material has a refractive index between about 1.37 and about 1.45.
19. The composition of claim 8 wherein said hydrogel polymer is selected from the group consisting of homopolymers and compolymers comprising polyHEMA, PVOH.
20. The composition of claim 13 wherein said hydrogel polymer further comprises comonomers selected from the group consisting of acrylic acid, methacrylic acid, vinyl pyrrolidone, N-vinyl methyl acetamide, N,N dimethyl acrylamide, acrylic acid, glycerol monomethacrylate, MPC (Ishihara monomer), methyl methacrylate, hydroxyethyl acrylate, N-(1,1-dimethyl-3-oxybutyl)acrylamide, polyethylene glycol monomethacrylate, polyethylene glycol dimethacrylate, 2-ethoxyethyl methacrylate, 2-methacryloxyethyl phosphorylcholine and mixtures thereof.
21. The composition of claim 1 wherein said oxygen permeable material is selected from the group consisting of crosslinked polydimethylsiloxane, poly((trimethyl silyl)propyne), as 2,2-bis(trifluoromethyl)-4,5-difluoro-1,3-dioxole copolymers with tetrafluoroethylene, fluorinated PDMS polymer and mixtures thereof.
22. The composition of claim 1 wherein said oxygen permeable material is selected from the group consisting of crosslinked fluorine containing polymers, crosslinked polydialkylsiloxane polymers, self-assembled siloxanes, rigid siloxane materials and combinations thereof.
23. The composition of claim 11 wherein said encapsulating material is selected from the group consisting of a liposomal, micellar or polymeric structures.
24. The composition of claim 23 wherein said encapsulating material comprises a polymer structure selected from the group consisting of anionic, cationic, zwitterionic, polar neutral compositions and mixtures thereof.
25. The composition of claim 1 where said oxygen permeable particle has an average particle size of less than about 1000 nm.
26. The composition of claim 11 wherein said encapsulated oxygen permeable particle comprises a loosely cross-linked poly(dimethylsiloxane) core and a hydrophilic shell.
27. The composition of claim 12 wherein said encapsulating material is biocompatible.
28. A composition comprising a hydrogel polymer having distributed therein oxygen permeable particles with an average particle size less than about 5000 nm and in an amount sufficient to increase the oxygen permeability of the hydrogel polymer by at least about 10 barrers.
29. The composition of claim 1 wherein said oxygen permeable particles have an average particle size of less than about 100 nm.
30. The composition of claim 1 further comprising a % haze of less than about 15%.
31. The composition of claim 1 where said oxygen permeable particles are spherical.
32. The composition of claim 1 wherein said oxygen permeable particles comprise are hollow nanostructures having an oxygen permeability of at least about 200 barrer and average particle size less than about 500 nm in its longest dimension.
33. The composition of claim 32 wherein said composition has an oxygen permeability of at least about 25 barrer.
34. The composition of claim 32 wherein said hollow nanostructures are spherical and have an average particle size of less than about 400 nm.
35. The composition of claim 32 wherein said hollow nanostructures are spherical and have an average particle size of about 10-100 nm.
36. The composition of claim 32 wherein said hollow nanostructures are elongated and have an average diameter of about 20 to about 100 nm and an average length of about 100 to about 5000 nm.
37. The composition of claim 32 where the hollow nanostructure comprise a critical pressure of at least 0.05 MPa
38. The composition of claim 32 wherein said hollow nanostructure comprises a critical pressure of at least 0.2 MPa
39. The composition of claim 32 wherein said hollow nanostructures comprise a shell surrounding a gas filled space, and wherein said shell at the interface of the gas filled space comprises at least one water impermeable material.
40. The composition of claim 39 wherein said shell further comprises at least one hydrophilic material encapsulating said at least one water impermeable material.
41. The composition of claim 32 wherein said hollow nanostructure comprises a gas vesicle protein.
42. The composition of claim 41 wherein said gas vesicle protein is encapsulated in a polymer or copolymer comprising repeating units of 2-hydroxyethyl methacryloyl.
43. The composition of claim 32 wherein said hollow nanostructure is encapsulated in a polymer or copolymer comprising repeating units derived from 2-hydroxyethyl methacrylate.
44. The composition of claim 41 wherein said gas vesicle protein comprises vesicle walls which are crosslinked.
45. The composition of claim 32 wherein said hollow nanostructure is formed from at least one synthetic material.
46. The composition of claim 32 wherein the hollow nanostructure is formed via emulsion polymerization over a template and said template is removed via dissolution after said nanostructure is formed.
47. The composition of claim 32 wherein the hollow nanostructure comprises a shell and at least a part of said shell comprises at least one inorganic component selected from the group consisting of metal oxides, boron nitrides, transition metal sulfides, metals, grapheme, perovskite oxide and combinations thereof.
48. The composition of claim 32 wherein said hollow nanostructure are cylindrical with conical endcaps.
49. The composition of claim 32 wherein said hollow nanostructures have a shape selected from the group consisting of regular or irregular polyhedra, ellipsoids, cones, spheroids and combinations thereof.
50. The composition of claim 32 wherein said hollow nanostructures are reactive.
51. The composition of claim 32 wherein said synthetic hollow nanostructures are crosslinked.
52. A medical device formed from the composition of claim 1 .
53. An ophthalmic device formed from the composition of claim 1 .
54. A contact lens formed from the composition of claim 1 .
55. A contact lens comprising a hydrogel polymer having distributed in a region outside the optic zone of said contact lens an oxygen enhancing effective amount of oxygen permeable particles having an oxygen permeability of at least about 100 barrer and average particle size of between about 200 nm and 100 microns.
Priority Applications (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/721,081 US20100249273A1 (en) | 2009-03-31 | 2010-03-10 | Polymeric articles comprising oxygen permeability enhancing particles |
| PCT/US2010/027840 WO2010117588A1 (en) | 2009-03-31 | 2010-03-18 | Polymeric articles comprising oxygen permeability enhancing particles |
| CN201080015758.2A CN102378783B (en) | 2009-03-31 | 2010-03-18 | Polymeric articles comprising oxygen permeability enhancing particles |
| AU2010235011A AU2010235011A1 (en) | 2009-03-31 | 2010-03-18 | Polymeric articles comprising oxygen permeability enhancing particles |
| CA2753226A CA2753226A1 (en) | 2009-03-31 | 2010-03-18 | Polymeric articles comprising oxygen permeability enhancing particles |
| JP2012503479A JP2012522111A (en) | 2009-03-31 | 2010-03-18 | Polymer articles comprising oxygen permeable reinforcing particles |
| SG2011063260A SG174219A1 (en) | 2009-03-31 | 2010-03-18 | Polymeric articles comprising oxygen permeability enhancing particles |
| KR1020117025619A KR20120003474A (en) | 2009-03-31 | 2010-03-18 | Polymer article comprising oxygen permeability enhancing particles |
| EP10723394A EP2414443A1 (en) | 2009-03-31 | 2010-03-18 | Polymeric articles comprising oxygen permeability enhancing particles |
| BRPI1014058A BRPI1014058A2 (en) | 2009-03-31 | 2010-03-18 | polymer articles comprising particles that enhance oxygen permeability |
| RU2011143748/05A RU2011143748A (en) | 2009-03-31 | 2010-03-18 | POLYMERIC PRODUCTS INCLUDING PARTICLES INCREASING PERFORMANCE FOR OXYGEN |
| TW099109570A TW201105728A (en) | 2009-03-31 | 2010-03-30 | Polymeric articles comprising oxygen permeability enhancing particles |
| ARP100101068A AR076022A1 (en) | 2009-03-31 | 2010-03-31 | POLYMERIC ITEMS THAT INCLUDE PARTICLES THAT INCREASE PERMEABILITY TO OXYGEN |
| US13/737,364 US8513324B2 (en) | 2009-03-31 | 2013-01-09 | Polymeric articles comprising oxygen permeability enhancing particles |
| US14/028,201 US9062180B2 (en) | 2009-03-31 | 2013-09-16 | Polymeric articles comprising oxygen permeability enhancing particles |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16493109P | 2009-03-31 | 2009-03-31 | |
| US25227909P | 2009-10-16 | 2009-10-16 | |
| US12/721,081 US20100249273A1 (en) | 2009-03-31 | 2010-03-10 | Polymeric articles comprising oxygen permeability enhancing particles |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/737,364 Division US8513324B2 (en) | 2009-03-31 | 2013-01-09 | Polymeric articles comprising oxygen permeability enhancing particles |
| US14/028,201 Division US9062180B2 (en) | 2009-03-31 | 2013-09-16 | Polymeric articles comprising oxygen permeability enhancing particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20100249273A1 true US20100249273A1 (en) | 2010-09-30 |
Family
ID=42785036
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/721,081 Abandoned US20100249273A1 (en) | 2009-03-31 | 2010-03-10 | Polymeric articles comprising oxygen permeability enhancing particles |
| US13/737,364 Expired - Fee Related US8513324B2 (en) | 2009-03-31 | 2013-01-09 | Polymeric articles comprising oxygen permeability enhancing particles |
| US14/028,201 Active US9062180B2 (en) | 2009-03-31 | 2013-09-16 | Polymeric articles comprising oxygen permeability enhancing particles |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/737,364 Expired - Fee Related US8513324B2 (en) | 2009-03-31 | 2013-01-09 | Polymeric articles comprising oxygen permeability enhancing particles |
| US14/028,201 Active US9062180B2 (en) | 2009-03-31 | 2013-09-16 | Polymeric articles comprising oxygen permeability enhancing particles |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20100249273A1 (en) |
| EP (1) | EP2414443A1 (en) |
| JP (1) | JP2012522111A (en) |
| KR (1) | KR20120003474A (en) |
| CN (1) | CN102378783B (en) |
| AR (1) | AR076022A1 (en) |
| AU (1) | AU2010235011A1 (en) |
| BR (1) | BRPI1014058A2 (en) |
| CA (1) | CA2753226A1 (en) |
| RU (1) | RU2011143748A (en) |
| SG (1) | SG174219A1 (en) |
| TW (1) | TW201105728A (en) |
| WO (1) | WO2010117588A1 (en) |
Cited By (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012093774A3 (en) * | 2011-01-07 | 2012-09-07 | 주식회사 케이씨아이 | Cross-linked copolymer containing phosphorylcholine monomer and cosmetic composition containing same |
| WO2013085814A2 (en) | 2011-12-08 | 2013-06-13 | Johnson & Johnson Vision Care, Inc. | Monomer systems with dispersed silicone-based engineered particles |
| WO2013090780A1 (en) * | 2011-12-14 | 2013-06-20 | Semprus Biosciences Corp. | Surface modified contact lenses |
| WO2013112875A1 (en) * | 2012-01-25 | 2013-08-01 | The University Of Akron | Wound dressings with enhanced gas permeation and other beneficial properties |
| US8513324B2 (en) | 2009-03-31 | 2013-08-20 | Johnson & Johnson Vision Care, Inc. | Polymeric articles comprising oxygen permeability enhancing particles |
| WO2013158308A1 (en) * | 2012-04-19 | 2013-10-24 | Soane Energy, Llc | Self-suspending proppants for hydraulic fracturing |
| WO2013192438A3 (en) * | 2012-06-21 | 2014-04-17 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| CN103764948A (en) * | 2011-08-31 | 2014-04-30 | 自悬浮支撑有限公司 | Self-suspending proppants for hydraulic fracturing |
| WO2013192634A3 (en) * | 2012-06-21 | 2014-05-08 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| US8870372B2 (en) | 2011-12-14 | 2014-10-28 | Semprus Biosciences Corporation | Silicone hydrogel contact lens modified using lanthanide or transition metal oxidants |
| US9000063B2 (en) | 2011-12-14 | 2015-04-07 | Semprus Biosciences Corporation | Multistep UV process to create surface modified contact lenses |
| US9006359B2 (en) | 2011-12-14 | 2015-04-14 | Semprus Biosciences Corporation | Imbibing process for contact lens surface modification |
| US9120119B2 (en) | 2011-12-14 | 2015-09-01 | Semprus Biosciences Corporation | Redox processes for contact lens modification |
| US9610546B2 (en) | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
| US9644139B2 (en) | 2011-08-31 | 2017-05-09 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| US20170139232A1 (en) * | 2015-11-13 | 2017-05-18 | Hon Hai Precision Industry Co., Ltd. | Colored contact lens |
| US9744617B2 (en) | 2014-01-31 | 2017-08-29 | Lockheed Martin Corporation | Methods for perforating multi-layer graphene through ion bombardment |
| US9834809B2 (en) | 2014-02-28 | 2017-12-05 | Lockheed Martin Corporation | Syringe for obtaining nano-sized materials for selective assays and related methods of use |
| US9833748B2 (en) | 2010-08-25 | 2017-12-05 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
| US9844757B2 (en) | 2014-03-12 | 2017-12-19 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
| US9845428B2 (en) | 2009-10-20 | 2017-12-19 | Self-Suspending Proppant Llc | Proppants for hydraulic fracturing technologies |
| US9870895B2 (en) | 2014-01-31 | 2018-01-16 | Lockheed Martin Corporation | Methods for perforating two-dimensional materials using a broad ion field |
| US9868896B2 (en) | 2011-08-31 | 2018-01-16 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| US9932521B2 (en) | 2014-03-05 | 2018-04-03 | Self-Suspending Proppant, Llc | Calcium ion tolerant self-suspending proppants |
| US10005038B2 (en) | 2014-09-02 | 2018-06-26 | Lockheed Martin Corporation | Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same |
| US10017852B2 (en) | 2016-04-14 | 2018-07-10 | Lockheed Martin Corporation | Method for treating graphene sheets for large-scale transfer using free-float method |
| US20180273836A1 (en) * | 2015-10-22 | 2018-09-27 | Halliburton Energy Services, Inc. | Multifunctional brush photopolymerized coated proppant particulates use in subterranean formation operations |
| US10101499B2 (en) | 2012-03-22 | 2018-10-16 | Momentive Performance Materials Inc. | Hydrophilic macromers and hydrogels comprising the same |
| US10118130B2 (en) | 2016-04-14 | 2018-11-06 | Lockheed Martin Corporation | Two-dimensional membrane structures having flow passages |
| US10201784B2 (en) | 2013-03-12 | 2019-02-12 | Lockheed Martin Corporation | Method for forming perforated graphene with uniform aperture size |
| US10203295B2 (en) | 2016-04-14 | 2019-02-12 | Lockheed Martin Corporation | Methods for in situ monitoring and control of defect formation or healing |
| US10213746B2 (en) | 2016-04-14 | 2019-02-26 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
| US10330951B2 (en) | 2013-11-15 | 2019-06-25 | Tangible Science, Llc | Contact lens with a hydrophilic layer |
| US10376845B2 (en) | 2016-04-14 | 2019-08-13 | Lockheed Martin Corporation | Membranes with tunable selectivity |
| US10418143B2 (en) | 2015-08-05 | 2019-09-17 | Lockheed Martin Corporation | Perforatable sheets of graphene-based material |
| US10451896B2 (en) | 2012-08-27 | 2019-10-22 | Tangible Science, Llc | Contact lens with a hydrophilic layer |
| US10471199B2 (en) | 2013-06-21 | 2019-11-12 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
| US10500546B2 (en) | 2014-01-31 | 2019-12-10 | Lockheed Martin Corporation | Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer |
| US10525170B2 (en) | 2014-12-09 | 2020-01-07 | Tangible Science, Llc | Medical device coating with a biocompatible layer |
| US20200131083A1 (en) * | 2017-06-21 | 2020-04-30 | Nikon Corporation | Nanostructured Transparent Article with Both Hydrophobic and Antifog Properties and Methods for Making It |
| US10653824B2 (en) | 2012-05-25 | 2020-05-19 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
| US10696554B2 (en) | 2015-08-06 | 2020-06-30 | Lockheed Martin Corporation | Nanoparticle modification and perforation of graphene |
| US10980919B2 (en) | 2016-04-14 | 2021-04-20 | Lockheed Martin Corporation | Methods for in vivo and in vitro use of graphene and other two-dimensional materials |
| US20210179882A1 (en) * | 2017-11-29 | 2021-06-17 | Sumitomo Chemical Company, Limited | Coating liquid for forming gas barrier layer |
| CN115298573A (en) * | 2020-03-19 | 2022-11-04 | 爱尔康公司 | High refractive index silicone insert materials for embedded contact lenses |
| US11530292B2 (en) * | 2016-11-09 | 2022-12-20 | Basf Se | Polyurethane comprising graphene nano structure |
| US11713415B2 (en) | 2018-11-21 | 2023-08-01 | Covia Solutions Inc. | Salt-tolerant self-suspending proppants made without extrusion |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9522980B2 (en) | 2010-05-06 | 2016-12-20 | Johnson & Johnson Vision Care, Inc. | Non-reactive, hydrophilic polymers having terminal siloxanes and methods for making and using the same |
| US20130203813A1 (en) | 2011-05-04 | 2013-08-08 | Johnson & Johnson Vision Care, Inc. | Medical devices having homogeneous charge density and methods for making same |
| US9170349B2 (en) | 2011-05-04 | 2015-10-27 | Johnson & Johnson Vision Care, Inc. | Medical devices having homogeneous charge density and methods for making same |
| CN102382237B (en) * | 2011-08-12 | 2013-07-10 | 北京自然美光学有限公司 | Radiation-proof light-filtering contact lens and production method thereof |
| US8937111B2 (en) * | 2011-12-23 | 2015-01-20 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogels comprising desirable water content and oxygen permeability |
| US9140825B2 (en) | 2011-12-23 | 2015-09-22 | Johnson & Johnson Vision Care, Inc. | Ionic silicone hydrogels |
| US8937110B2 (en) | 2011-12-23 | 2015-01-20 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogels having a structure formed via controlled reaction kinetics |
| US9156934B2 (en) | 2011-12-23 | 2015-10-13 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogels comprising n-vinyl amides and hydroxyalkyl (meth)acrylates or (meth)acrylamides |
| US9588258B2 (en) | 2011-12-23 | 2017-03-07 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogels formed from zero diluent reactive mixtures |
| US10073192B2 (en) | 2012-05-25 | 2018-09-11 | Johnson & Johnson Vision Care, Inc. | Polymers and nanogel materials and methods for making and using the same |
| US9244196B2 (en) | 2012-05-25 | 2016-01-26 | Johnson & Johnson Vision Care, Inc. | Polymers and nanogel materials and methods for making and using the same |
| US9297929B2 (en) | 2012-05-25 | 2016-03-29 | Johnson & Johnson Vision Care, Inc. | Contact lenses comprising water soluble N-(2 hydroxyalkyl) (meth)acrylamide polymers or copolymers |
| US8937133B2 (en) | 2012-09-25 | 2015-01-20 | National Chiao Tung University | Dissoluble PDMS-modified p(HEMA-MAA) amphiphilic copolymer and method for fabricating the same |
| US9956168B2 (en) | 2013-06-20 | 2018-05-01 | Mercy Medical Research Institute | Extended release drug-delivery contact lenses and methods of making |
| CN104448407B (en) * | 2014-12-12 | 2015-09-02 | 青岛中皓生物工程有限公司 | Based on high oxygen permeability material and preparation method thereof and the application of marine organisms material |
| WO2016138528A1 (en) * | 2015-02-27 | 2016-09-01 | Wayne State University | Methods and compositions relating to biocompatible implants |
| TWI636297B (en) * | 2016-02-05 | 2018-09-21 | 逢甲大學 | Hydrogel film of contact lenses and manufacturing method thereof |
| US10488677B2 (en) | 2016-03-03 | 2019-11-26 | Verily Life Sciences Llc | Electronics embedded in rigid gas permeable contact lenses |
| JP7208345B2 (en) * | 2016-03-11 | 2023-01-18 | イノベーガ,インコーポレイテッド | contact lens |
| EP3446159B1 (en) | 2016-04-20 | 2023-06-14 | CooperVision International Limited | Silicone elastomer-silicone hydrogel hybrid contact lenses |
| US20180169905A1 (en) | 2016-12-16 | 2018-06-21 | Coopervision International Holding Company, Lp | Contact Lenses With Incorporated Components |
| US10509238B2 (en) | 2017-04-14 | 2019-12-17 | Verily Life Sciences Llc | Electrowetting opthalmic optics including gas-permeable components |
| WO2018226841A1 (en) | 2017-06-06 | 2018-12-13 | Wayne State University | Methods and compositions relating to carnitine- derived materials |
| CN111093958B (en) | 2017-09-08 | 2022-10-28 | 威里利生命科学有限责任公司 | Self-healing lead in a humid environment |
| KR20190054906A (en) | 2017-11-13 | 2019-05-22 | 이형교 | Coffee dripper |
| TWI640558B (en) * | 2017-11-17 | 2018-11-11 | Benq Materials Corporation | Ophthalmic lens and manufacturing method thereof |
| EP3746820B1 (en) * | 2018-01-30 | 2022-02-16 | Alcon Inc. | Contact lenses with a lubricious coating thereon |
| TW202009013A (en) * | 2018-08-14 | 2020-03-01 | 優你康光學股份有限公司 | Contact lenses with functional ingredients and their products |
| WO2020230793A1 (en) * | 2019-05-13 | 2020-11-19 | 国立大学法人東京大学 | Technology for controlling migration of hollow nanoparticles to brain from blood |
| WO2021061586A1 (en) | 2019-09-24 | 2021-04-01 | Gpcp Ip Holdings Llc | Microencapsulated probiotic and compositions containing the same |
| CN110935328B (en) * | 2019-11-12 | 2022-02-11 | 南京工业大学 | Preparation method of organic fluorine-containing polymer doped perovskite hollow fiber oxygen permeable membrane |
Citations (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3408429A (en) * | 1963-09-11 | 1968-10-29 | Ceskoslovenska Akademie Ved | Method for centrifugal casting a contact lens |
| US3660545A (en) * | 1961-12-27 | 1972-05-02 | Ceskoslovenska Akademie Ved | Method of centrifugally casting thin edged corneal contact lenses |
| US3996187A (en) * | 1975-04-29 | 1976-12-07 | American Optical Corporation | Optically clear filled silicone elastomers |
| US4113224A (en) * | 1975-04-08 | 1978-09-12 | Bausch & Lomb Incorporated | Apparatus for forming optical lenses |
| US4197266A (en) * | 1974-05-06 | 1980-04-08 | Bausch & Lomb Incorporated | Method for forming optical lenses |
| US4680336A (en) * | 1984-11-21 | 1987-07-14 | Vistakon, Inc. | Method of forming shaped hydrogel articles |
| US4701038A (en) * | 1983-01-31 | 1987-10-20 | Bausch & Lomb Incorporated | Cosmetic contact lens |
| US4701288A (en) * | 1985-06-05 | 1987-10-20 | Bausch & Lomb Incorporated | Method of making articles of dissimilar polymer compositions |
| US4889664A (en) * | 1988-11-25 | 1989-12-26 | Vistakon, Inc. | Method of forming shaped hydrogel articles including contact lenses |
| US4900764A (en) * | 1985-11-25 | 1990-02-13 | Highgate Donald J | Hydrophilic materials |
| US5039459A (en) * | 1988-11-25 | 1991-08-13 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses |
| US5457140A (en) * | 1993-07-22 | 1995-10-10 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses using inert, displaceable diluents |
| US5661215A (en) * | 1995-07-26 | 1997-08-26 | Dow Corning Corporation | Microemulsions of gel-free polymers |
| US5910519A (en) * | 1995-03-24 | 1999-06-08 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses using inert, displaceable diluents |
| US6316541B1 (en) * | 1990-06-01 | 2001-11-13 | Dow Corning Corporation | Method for making polysiloxane emulsions |
| US6638994B2 (en) * | 2001-03-30 | 2003-10-28 | Regan Crooks | Aqueous suspension of nanoparticles comprising an agrochemical active ingredient |
| US20040120982A1 (en) * | 2002-12-19 | 2004-06-24 | Zanini Diana | Biomedical devices with coatings attached via latent reactive components |
| US20050255231A1 (en) * | 2003-06-30 | 2005-11-17 | Hill Gregory A | Silicone hydrogels having consistent concentrations of multi-functional polysiloxanes |
| US20060063852A1 (en) * | 2004-08-27 | 2006-03-23 | Asahikasei Aime Co. Ltd. | Silicone hydrogel contact lens |
| WO2007005249A2 (en) * | 2005-06-29 | 2007-01-11 | Hyperbranch Medical Technology, Inc. | Nanoparticles and dendritic-polymer-based hydrogels comprising them |
| US7723438B2 (en) * | 2005-04-28 | 2010-05-25 | International Business Machines Corporation | Surface-decorated polymeric amphiphile porogens for the templation of nanoporous materials |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4143949A (en) * | 1976-10-28 | 1979-03-13 | Bausch & Lomb Incorporated | Process for putting a hydrophilic coating on a hydrophobic contact lens |
| US4550139A (en) * | 1982-03-22 | 1985-10-29 | Petrarch Systems, Inc. | Mixtures of polyacrylate resins and siloxane-styrene copolymers |
| US4478981A (en) * | 1982-03-22 | 1984-10-23 | Petrarch Systems Inc. | Mixtures of polyacrylate resins and siloxane carbonate copolymers |
| GB8818217D0 (en) | 1988-07-30 | 1988-09-01 | Polymer Lab Ltd | Contact lenses |
| JPH03294818A (en) * | 1990-04-13 | 1991-12-26 | Seiko Epson Corp | Soft contact lens |
| US5490059A (en) | 1994-09-02 | 1996-02-06 | Advanced Micro Devices, Inc. | Heuristic clock speed optimizing mechanism and computer system employing the same |
| WO1997010527A1 (en) * | 1995-09-14 | 1997-03-20 | The Regents Of The University Of California | Structured index optics and ophthalmic lenses for vision correction |
| EP0956337A4 (en) | 1996-11-12 | 2004-12-22 | Univ Akron | COMPOSITIONS AND METHODS RELATING TO THE PRODUCTION, ISOLATION AND MODIFICATION OF GAS MICROBUBBLES |
| US7052131B2 (en) * | 2001-09-10 | 2006-05-30 | J&J Vision Care, Inc. | Biomedical devices containing internal wetting agents |
| JP4219485B2 (en) * | 1999-05-21 | 2009-02-04 | 株式会社メニコン | Ophthalmic material composed of optical hydrous gel |
| EP2202254A1 (en) * | 1999-10-07 | 2010-06-30 | Johson & Johnson Vision Care Inc. | Soft contact lenses |
| EP1267802A2 (en) * | 2000-03-31 | 2003-01-02 | The Procter & Gamble Company | Leave-in hair cosmetic compositions for enhancing volume containing microspheres |
| US6774178B2 (en) * | 2001-01-05 | 2004-08-10 | Novartis Ag | Tinted, high Dk ophthalmic molding and a method for making same |
| JP2003294818A (en) | 2002-03-28 | 2003-10-15 | Asahi Kasei Corp | Magnetic sensor and method of manufacturing the same |
| US6806337B2 (en) * | 2002-07-16 | 2004-10-19 | Alcon | Ophthalmic and otorhinolaryngological device materials |
| CA2518108C (en) | 2003-03-07 | 2014-07-08 | Johnson & Johnson Vision Care, Inc. | Diluents for forming clear, wettable silicone hydrogel articles |
| CN101163991A (en) * | 2004-08-27 | 2008-04-16 | 旭化成爱目股份有限公司 | Silicone Hydrogel Contact Lenses |
| US7249848B2 (en) | 2004-09-30 | 2007-07-31 | Johnson & Johnson Vision Care, Inc. | Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents |
| WO2006091653A2 (en) * | 2005-02-23 | 2006-08-31 | The Regents Of The University Of California | Flexible hydrogel-based functional composite materials |
| JP2007077346A (en) * | 2005-09-16 | 2007-03-29 | Masamitsu Nagahama | Composite materials, methods for producing composite materials, use of granular materials |
| US20070155851A1 (en) * | 2005-12-30 | 2007-07-05 | Azaam Alli | Silicone containing polymers formed from non-reactive silicone containing prepolymers |
| WO2007076871A1 (en) | 2006-01-04 | 2007-07-12 | Københavns Universitet | Method and apparatus for effecting complete analgesia |
| US20080260833A1 (en) * | 2007-04-20 | 2008-10-23 | Thomas Hirt | Drug delivery vehicle containing vesicles in a hydrogel base |
| WO2008154505A1 (en) * | 2007-06-08 | 2008-12-18 | The Regents Of The University Of California | Biodegradable synthetic bone composites |
| US20090092542A1 (en) * | 2007-10-09 | 2009-04-09 | Smyth Stuart K J | Bioinert tissue marker |
| TW200927792A (en) | 2007-12-28 | 2009-07-01 | Far Eastern Textile Ltd | Silicon-containing prepolymer and silicon containing hydrogel and contact lens made therefrom |
| US20090275815A1 (en) * | 2008-03-21 | 2009-11-05 | Nova Biomedical Corporation | Temperature-compensated in-vivo sensor |
| US20100249273A1 (en) | 2009-03-31 | 2010-09-30 | Scales Charles W | Polymeric articles comprising oxygen permeability enhancing particles |
-
2010
- 2010-03-10 US US12/721,081 patent/US20100249273A1/en not_active Abandoned
- 2010-03-18 JP JP2012503479A patent/JP2012522111A/en active Pending
- 2010-03-18 CA CA2753226A patent/CA2753226A1/en not_active Abandoned
- 2010-03-18 EP EP10723394A patent/EP2414443A1/en not_active Withdrawn
- 2010-03-18 SG SG2011063260A patent/SG174219A1/en unknown
- 2010-03-18 AU AU2010235011A patent/AU2010235011A1/en not_active Abandoned
- 2010-03-18 KR KR1020117025619A patent/KR20120003474A/en not_active Withdrawn
- 2010-03-18 CN CN201080015758.2A patent/CN102378783B/en not_active Expired - Fee Related
- 2010-03-18 WO PCT/US2010/027840 patent/WO2010117588A1/en not_active Ceased
- 2010-03-18 RU RU2011143748/05A patent/RU2011143748A/en unknown
- 2010-03-18 BR BRPI1014058A patent/BRPI1014058A2/en not_active Application Discontinuation
- 2010-03-30 TW TW099109570A patent/TW201105728A/en unknown
- 2010-03-31 AR ARP100101068A patent/AR076022A1/en unknown
-
2013
- 2013-01-09 US US13/737,364 patent/US8513324B2/en not_active Expired - Fee Related
- 2013-09-16 US US14/028,201 patent/US9062180B2/en active Active
Patent Citations (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3660545A (en) * | 1961-12-27 | 1972-05-02 | Ceskoslovenska Akademie Ved | Method of centrifugally casting thin edged corneal contact lenses |
| US3408429A (en) * | 1963-09-11 | 1968-10-29 | Ceskoslovenska Akademie Ved | Method for centrifugal casting a contact lens |
| US4197266A (en) * | 1974-05-06 | 1980-04-08 | Bausch & Lomb Incorporated | Method for forming optical lenses |
| US4113224A (en) * | 1975-04-08 | 1978-09-12 | Bausch & Lomb Incorporated | Apparatus for forming optical lenses |
| US3996187A (en) * | 1975-04-29 | 1976-12-07 | American Optical Corporation | Optically clear filled silicone elastomers |
| US4701038A (en) * | 1983-01-31 | 1987-10-20 | Bausch & Lomb Incorporated | Cosmetic contact lens |
| US4680336A (en) * | 1984-11-21 | 1987-07-14 | Vistakon, Inc. | Method of forming shaped hydrogel articles |
| US4701288A (en) * | 1985-06-05 | 1987-10-20 | Bausch & Lomb Incorporated | Method of making articles of dissimilar polymer compositions |
| US4900764A (en) * | 1985-11-25 | 1990-02-13 | Highgate Donald J | Hydrophilic materials |
| US4889664A (en) * | 1988-11-25 | 1989-12-26 | Vistakon, Inc. | Method of forming shaped hydrogel articles including contact lenses |
| US5039459A (en) * | 1988-11-25 | 1991-08-13 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses |
| US6316541B1 (en) * | 1990-06-01 | 2001-11-13 | Dow Corning Corporation | Method for making polysiloxane emulsions |
| US5490960A (en) * | 1993-07-22 | 1996-02-13 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses using inert, displaceable diluents |
| US5457140A (en) * | 1993-07-22 | 1995-10-10 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses using inert, displaceable diluents |
| US5594043A (en) * | 1993-07-22 | 1997-01-14 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses using inert, displaceable diluents |
| US5498379A (en) * | 1993-07-22 | 1996-03-12 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses using inert, displaceable diluents |
| US5684058A (en) * | 1993-07-22 | 1997-11-04 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses using inert, displaceable diluents |
| US5736409A (en) * | 1993-07-22 | 1998-04-07 | Johnson & Johnson Vision Products, Inc. | Method of testing inert, displaceable diluents used in forming shaped hydrogel articles |
| US5910519A (en) * | 1995-03-24 | 1999-06-08 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses using inert, displaceable diluents |
| US5661215A (en) * | 1995-07-26 | 1997-08-26 | Dow Corning Corporation | Microemulsions of gel-free polymers |
| US6638994B2 (en) * | 2001-03-30 | 2003-10-28 | Regan Crooks | Aqueous suspension of nanoparticles comprising an agrochemical active ingredient |
| US20040120982A1 (en) * | 2002-12-19 | 2004-06-24 | Zanini Diana | Biomedical devices with coatings attached via latent reactive components |
| US20050255231A1 (en) * | 2003-06-30 | 2005-11-17 | Hill Gregory A | Silicone hydrogels having consistent concentrations of multi-functional polysiloxanes |
| US20060063852A1 (en) * | 2004-08-27 | 2006-03-23 | Asahikasei Aime Co. Ltd. | Silicone hydrogel contact lens |
| US7723438B2 (en) * | 2005-04-28 | 2010-05-25 | International Business Machines Corporation | Surface-decorated polymeric amphiphile porogens for the templation of nanoporous materials |
| WO2007005249A2 (en) * | 2005-06-29 | 2007-01-11 | Hyperbranch Medical Technology, Inc. | Nanoparticles and dendritic-polymer-based hydrogels comprising them |
Cited By (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9062180B2 (en) | 2009-03-31 | 2015-06-23 | Johnson & Johnson Vision Care, Inc. | Polymeric articles comprising oxygen permeability enhancing particles |
| US8513324B2 (en) | 2009-03-31 | 2013-08-20 | Johnson & Johnson Vision Care, Inc. | Polymeric articles comprising oxygen permeability enhancing particles |
| US9845427B2 (en) | 2009-10-20 | 2017-12-19 | Self-Suspending Proppant Llc | Proppants for hydraulic fracturing technologies |
| US9845428B2 (en) | 2009-10-20 | 2017-12-19 | Self-Suspending Proppant Llc | Proppants for hydraulic fracturing technologies |
| US9833748B2 (en) | 2010-08-25 | 2017-12-05 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
| US9084739B2 (en) | 2011-01-07 | 2015-07-21 | Kci Limited | Cross-linked copolymer containing phosphorylcholine monomer and cosmetic composition containing same |
| WO2012093774A3 (en) * | 2011-01-07 | 2012-09-07 | 주식회사 케이씨아이 | Cross-linked copolymer containing phosphorylcholine monomer and cosmetic composition containing same |
| CN103764948A (en) * | 2011-08-31 | 2014-04-30 | 自悬浮支撑有限公司 | Self-suspending proppants for hydraulic fracturing |
| US9644139B2 (en) | 2011-08-31 | 2017-05-09 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| US9845429B2 (en) | 2011-08-31 | 2017-12-19 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| US9297244B2 (en) | 2011-08-31 | 2016-03-29 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing comprising a coating of hydrogel-forming polymer |
| US9868896B2 (en) | 2011-08-31 | 2018-01-16 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| US10472943B2 (en) | 2011-08-31 | 2019-11-12 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| US9315721B2 (en) | 2011-08-31 | 2016-04-19 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| US10316244B2 (en) | 2011-08-31 | 2019-06-11 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| US9796916B2 (en) | 2011-08-31 | 2017-10-24 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| JP2015500512A (en) * | 2011-12-08 | 2015-01-05 | ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッドJohnson & Johnson Vision Care, Inc. | Monomer system with dispersed silicone-based engineering particles |
| TWI572883B (en) * | 2011-12-08 | 2017-03-01 | 壯生和壯生視覺關懷公司 | Monomer systems with dispersed silicone-based engineered particles |
| US20130323295A1 (en) * | 2011-12-08 | 2013-12-05 | Johnson & Johnson Vision Care, Inc. | Monomer systems with dispersed silicone-based engineered particles |
| WO2013085814A3 (en) * | 2011-12-08 | 2013-08-01 | Johnson & Johnson Vision Care, Inc. | Monomer systems with dispersed silicone-based engineered particles |
| CN103975000A (en) * | 2011-12-08 | 2014-08-06 | 庄臣及庄臣视力保护公司 | Monomer systems with dispersed silicone-based engineered particles |
| WO2013085814A2 (en) | 2011-12-08 | 2013-06-13 | Johnson & Johnson Vision Care, Inc. | Monomer systems with dispersed silicone-based engineered particles |
| US9004682B2 (en) | 2011-12-14 | 2015-04-14 | Semprus Biosciences Corporation | Surface modified contact lenses |
| US8870372B2 (en) | 2011-12-14 | 2014-10-28 | Semprus Biosciences Corporation | Silicone hydrogel contact lens modified using lanthanide or transition metal oxidants |
| US9006359B2 (en) | 2011-12-14 | 2015-04-14 | Semprus Biosciences Corporation | Imbibing process for contact lens surface modification |
| US9000063B2 (en) | 2011-12-14 | 2015-04-07 | Semprus Biosciences Corporation | Multistep UV process to create surface modified contact lenses |
| WO2013090780A1 (en) * | 2011-12-14 | 2013-06-20 | Semprus Biosciences Corp. | Surface modified contact lenses |
| US9120119B2 (en) | 2011-12-14 | 2015-09-01 | Semprus Biosciences Corporation | Redox processes for contact lens modification |
| US9468700B2 (en) | 2012-01-25 | 2016-10-18 | The University Of Akron | Wound dressings with enhanced gas permeation and other beneficial properties |
| WO2013112875A1 (en) * | 2012-01-25 | 2013-08-01 | The University Of Akron | Wound dressings with enhanced gas permeation and other beneficial properties |
| US10101499B2 (en) | 2012-03-22 | 2018-10-16 | Momentive Performance Materials Inc. | Hydrophilic macromers and hydrogels comprising the same |
| WO2013158306A1 (en) * | 2012-04-19 | 2013-10-24 | Soane Energy, Llc | Self-suspending proppants for hydraulic fracturing |
| WO2013158308A1 (en) * | 2012-04-19 | 2013-10-24 | Soane Energy, Llc | Self-suspending proppants for hydraulic fracturing |
| CN104379697A (en) * | 2012-04-19 | 2015-02-25 | 自悬浮支撑有限公司 | Self-suspending proppants for hydraulic fracturing |
| RU2621239C2 (en) * | 2012-04-19 | 2017-06-01 | Селф-Саспендинг Проппант Ллс | Self-suspending proppants for hydraulic fracturing |
| CN104364343A (en) * | 2012-04-19 | 2015-02-18 | 自悬浮支撑有限公司 | Self-suspending proppants for hydraulic fracturing |
| US10653824B2 (en) | 2012-05-25 | 2020-05-19 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
| WO2013192438A3 (en) * | 2012-06-21 | 2014-04-17 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| WO2013192634A3 (en) * | 2012-06-21 | 2014-05-08 | Self-Suspending Proppant Llc | Self-suspending proppants for hydraulic fracturing |
| US11181754B2 (en) | 2012-08-27 | 2021-11-23 | Tangible Science, Llc | Contact lens with a hydrophilic layer |
| US12449674B2 (en) | 2012-08-27 | 2025-10-21 | Tangible Science, Inc. | Contact lens with a hydrophilic layer |
| US10451896B2 (en) | 2012-08-27 | 2019-10-22 | Tangible Science, Llc | Contact lens with a hydrophilic layer |
| US10201784B2 (en) | 2013-03-12 | 2019-02-12 | Lockheed Martin Corporation | Method for forming perforated graphene with uniform aperture size |
| US10471199B2 (en) | 2013-06-21 | 2019-11-12 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
| US10330951B2 (en) | 2013-11-15 | 2019-06-25 | Tangible Science, Llc | Contact lens with a hydrophilic layer |
| US11433628B2 (en) | 2013-11-15 | 2022-09-06 | Tangible Science, Inc. | Contact lens with a hydrophilic layer |
| US9744617B2 (en) | 2014-01-31 | 2017-08-29 | Lockheed Martin Corporation | Methods for perforating multi-layer graphene through ion bombardment |
| US9870895B2 (en) | 2014-01-31 | 2018-01-16 | Lockheed Martin Corporation | Methods for perforating two-dimensional materials using a broad ion field |
| US10500546B2 (en) | 2014-01-31 | 2019-12-10 | Lockheed Martin Corporation | Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer |
| US9834809B2 (en) | 2014-02-28 | 2017-12-05 | Lockheed Martin Corporation | Syringe for obtaining nano-sized materials for selective assays and related methods of use |
| US9932521B2 (en) | 2014-03-05 | 2018-04-03 | Self-Suspending Proppant, Llc | Calcium ion tolerant self-suspending proppants |
| US9844757B2 (en) | 2014-03-12 | 2017-12-19 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
| US9610546B2 (en) | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
| US10005038B2 (en) | 2014-09-02 | 2018-06-26 | Lockheed Martin Corporation | Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same |
| US11260150B2 (en) | 2014-12-09 | 2022-03-01 | Tangible Science, Inc. | Medical device coating with a biocompatible layer |
| US10525170B2 (en) | 2014-12-09 | 2020-01-07 | Tangible Science, Llc | Medical device coating with a biocompatible layer |
| US10418143B2 (en) | 2015-08-05 | 2019-09-17 | Lockheed Martin Corporation | Perforatable sheets of graphene-based material |
| US10696554B2 (en) | 2015-08-06 | 2020-06-30 | Lockheed Martin Corporation | Nanoparticle modification and perforation of graphene |
| US10662372B2 (en) * | 2015-10-22 | 2020-05-26 | Halliburton Energy Services, Inc. | Multifunctional brush photopolymerized coated proppant particulates use in subterranean formation operations |
| US20180273836A1 (en) * | 2015-10-22 | 2018-09-27 | Halliburton Energy Services, Inc. | Multifunctional brush photopolymerized coated proppant particulates use in subterranean formation operations |
| US20170139232A1 (en) * | 2015-11-13 | 2017-05-18 | Hon Hai Precision Industry Co., Ltd. | Colored contact lens |
| US10980919B2 (en) | 2016-04-14 | 2021-04-20 | Lockheed Martin Corporation | Methods for in vivo and in vitro use of graphene and other two-dimensional materials |
| US10017852B2 (en) | 2016-04-14 | 2018-07-10 | Lockheed Martin Corporation | Method for treating graphene sheets for large-scale transfer using free-float method |
| US10376845B2 (en) | 2016-04-14 | 2019-08-13 | Lockheed Martin Corporation | Membranes with tunable selectivity |
| US10981120B2 (en) | 2016-04-14 | 2021-04-20 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
| US10203295B2 (en) | 2016-04-14 | 2019-02-12 | Lockheed Martin Corporation | Methods for in situ monitoring and control of defect formation or healing |
| US10118130B2 (en) | 2016-04-14 | 2018-11-06 | Lockheed Martin Corporation | Two-dimensional membrane structures having flow passages |
| US10213746B2 (en) | 2016-04-14 | 2019-02-26 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
| US11608408B2 (en) * | 2016-11-09 | 2023-03-21 | Basf Se | Polyurethane comprising graphene nano structure |
| US11530292B2 (en) * | 2016-11-09 | 2022-12-20 | Basf Se | Polyurethane comprising graphene nano structure |
| US20200131083A1 (en) * | 2017-06-21 | 2020-04-30 | Nikon Corporation | Nanostructured Transparent Article with Both Hydrophobic and Antifog Properties and Methods for Making It |
| US12503390B2 (en) * | 2017-06-21 | 2025-12-23 | Nikon Corporation | Nanostructured transparent article with both hydrophobic and antifog properties and methods for making it |
| US20210179882A1 (en) * | 2017-11-29 | 2021-06-17 | Sumitomo Chemical Company, Limited | Coating liquid for forming gas barrier layer |
| US11713415B2 (en) | 2018-11-21 | 2023-08-01 | Covia Solutions Inc. | Salt-tolerant self-suspending proppants made without extrusion |
| CN115298573A (en) * | 2020-03-19 | 2022-11-04 | 爱尔康公司 | High refractive index silicone insert materials for embedded contact lenses |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102378783A (en) | 2012-03-14 |
| AR076022A1 (en) | 2011-05-11 |
| WO2010117588A1 (en) | 2010-10-14 |
| AU2010235011A1 (en) | 2011-09-08 |
| EP2414443A1 (en) | 2012-02-08 |
| US20130131214A1 (en) | 2013-05-23 |
| TW201105728A (en) | 2011-02-16 |
| RU2011143748A (en) | 2013-05-10 |
| BRPI1014058A2 (en) | 2016-04-12 |
| US20140171541A1 (en) | 2014-06-19 |
| CA2753226A1 (en) | 2010-10-14 |
| KR20120003474A (en) | 2012-01-10 |
| CN102378783B (en) | 2014-11-05 |
| US8513324B2 (en) | 2013-08-20 |
| JP2012522111A (en) | 2012-09-20 |
| SG174219A1 (en) | 2011-10-28 |
| US9062180B2 (en) | 2015-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9062180B2 (en) | Polymeric articles comprising oxygen permeability enhancing particles | |
| JP6348209B2 (en) | Silicone hydrogels formed from reactive mixtures without diluent | |
| US8410190B2 (en) | Wettable hydrogel materials for use in ophthalmic applications and methods | |
| TWI444408B (en) | Wettable silicone hydrogel contact lenses and related compositions and methods | |
| EP2483737B1 (en) | Silicone hydrogel contact lenses and methods of making silicone hydrogel contact lenses | |
| AU2019213690B2 (en) | Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use | |
| EP2681614B1 (en) | Wettable silicone hydrogel contact lenses | |
| CA3033154A1 (en) | Polymer compositions containing grafted polymeric networks and processes for their preparation and use | |
| HK1199652A1 (en) | Monomer systems with dispersed silicone-based engineered particles | |
| MX2008015849A (en) | Wettable silicone hydrogel contact lenses and related compositions and methods. | |
| TW200935117A (en) | Method for making contact lenses | |
| EP1971376A1 (en) | Silicone containing polymers formed from non-reactive silicone containing prepolymers | |
| US20100331443A1 (en) | Silicone hydrogels formed from symmetric hydroxyl functionalized siloxanes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: JOHNSON & JOHNSON VISION CARE, INC., FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SCALES, CHARLES W.;HILL, GREGORY A.;ENNS, JOHN B.;AND OTHERS;REEL/FRAME:024059/0932 Effective date: 20100310 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |